{"gene":"CDKL5","run_date":"2026-06-09T22:57:18","timeline":{"discoveries":[{"year":2005,"finding":"CDKL5 physically interacts with MeCP2 both in vivo and in vitro, and CDKL5 kinase activity mediates phosphorylation of MeCP2 as well as autophosphorylation, placing the two proteins in a common molecular pathway.","method":"Co-immunoprecipitation (in vivo), in vitro kinase assay, immunostaining","journal":"Human molecular genetics","confidence":"High","confidence_rationale":"Tier 1–2 / Moderate — in vitro kinase assay plus reciprocal Co-IP, replicated in same study across multiple experimental systems","pmids":["15917271"],"is_preprint":false},{"year":2005,"finding":"CDKL5 is a nuclear protein expressed in neurons during neural maturation and synaptogenesis, and its subcellular localization overlaps with MeCP2 in the nervous system.","method":"Immunostaining, Western blotting, fractionation","journal":"Human molecular genetics","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — direct localization by immunostaining in brain tissue with developmental staging","pmids":["15917271"],"is_preprint":false},{"year":2005,"finding":"Disease-causing missense mutations in the CDKL5 kinase domain, affecting highly conserved amino acids, impair catalytic activity as assessed by autophosphorylation, indicating that kinase inactivation underlies pathogenesis.","method":"In vitro autophosphorylation kinase assay with patient-derived mutant forms of CDKL5","journal":"American journal of human genetics","confidence":"Medium","confidence_rationale":"Tier 1 / Weak — in vitro kinase assay on patient-derived mutants, single study","pmids":["15499549"],"is_preprint":false},{"year":2005,"finding":"CDKL5 is primarily localized in the nucleus; removal of the C-terminal domain increases expression, enhances autophosphorylation activity, and causes perinuclear (cytoplasmic) localization, demonstrating that the C-terminus negatively regulates kinase activity and controls nuclear localization.","method":"Transfection of C-terminal deletion constructs, subcellular fractionation, in vitro kinase assay","journal":"Human molecular genetics","confidence":"Medium","confidence_rationale":"Tier 1–2 / Weak — in vitro kinase assay plus localization by fractionation, single lab","pmids":["16330482"],"is_preprint":false},{"year":2005,"finding":"CDKL5 detected binding to MeCP2 but not to ARX; neither MeCP2 nor ARX was confirmed as a direct phosphorylation substrate by CDKL5 in this study (negative finding for direct MeCP2 phosphorylation).","method":"Co-immunoprecipitation, in vitro kinase assay","journal":"Human molecular genetics","confidence":"Low","confidence_rationale":"Tier 2 / Weak — single lab, single Co-IP, contradicts paper 15917271; noted as negative finding","pmids":["16330482"],"is_preprint":false},{"year":2006,"finding":"Disease-causing CDKL5 mutations show both impaired and increased catalytic activity relative to wild-type; wild-type CDKL5 autophosphorylates its TEY motif and phosphorylates MeCP2 in vitro; CDKL5 can self-associate (homo-oligomerize); the C-terminus negatively regulates catalytic activity and is required for proper sub-nuclear localization.","method":"In vitro kinase assay, TEY phosphorylation analysis, co-immunoprecipitation for self-association, subcellular localization by immunofluorescence","journal":"The Journal of biological chemistry","confidence":"High","confidence_rationale":"Tier 1–2 / Moderate — in vitro kinase assay plus mutagenesis plus Co-IP plus localization, multiple orthogonal methods in one study","pmids":["16935860"],"is_preprint":false},{"year":2008,"finding":"CDKL5 subcellular distribution is regulated by its C-terminal tail: the C-terminus is required for cytoplasmic localization via active nuclear export, while Rett-syndrome truncations of the C-terminus cause constitutive nuclear accumulation. CDKL5 shuttles between nucleus and cytoplasm during neuronal development.","method":"Immunostaining of brain sections, subcellular fractionation, C-terminal deletion/truncation constructs, nuclear export inhibition","journal":"The Journal of biological chemistry","confidence":"High","confidence_rationale":"Tier 2 / Moderate — direct localization experiments combined with deletion constructs and nuclear export inhibition, multiple orthogonal methods","pmids":["18701457"],"is_preprint":false},{"year":2009,"finding":"CDKL5 localizes to nuclear speckles (pre-mRNA splicing factor storage/modification sites), regulates their morphology in a kinase-activity-dependent manner, and influences alternative splicing activity.","method":"Immunofluorescence co-localization with speckle markers, CDKL5 overexpression/knockdown, minigene splicing assay","journal":"Human molecular genetics","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — direct localization by immunofluorescence plus functional minigene assay plus knockdown, single lab","pmids":["19740913"],"is_preprint":false},{"year":2010,"finding":"Cdkl5 is a MeCP2-repressed target gene: increased MeCP2 levels repress Cdkl5 expression, Cdkl5 promoter methylation increases upon MeCP2 upregulation, and MeCP2 binds the methylated Cdkl5 promoter; siRNA knockdown of MeCP2 or inhibition of DNA methyltransferases induces Cdkl5 expression.","method":"MeCP2 overexpression/siRNA knockdown, DNA methylation analysis, chromatin immunoprecipitation (ChIP), quantitative PCR","journal":"Neurobiology of disease","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — ChIP plus methylation analysis plus functional rescue experiments, single lab","pmids":["20211261"],"is_preprint":false},{"year":2010,"finding":"CDKL5 regulates neuronal morphogenesis via Rac1 signaling: CDKL5 colocalizes and forms a protein complex with Rac1 in neurons and fibroblasts; CDKL5 knockdown inhibits neurite growth and dendritic arborization; overexpression of Rac1 rescues dendritic defects from CDKL5 knockdown; dominant-negative Rac1 abolishes the growth-promoting effect of CDKL5; CDKL5 is required for BDNF-induced Rac1 activation.","method":"RNAi knockdown, overexpression, in utero electroporation, Co-immunoprecipitation, Rac1 activation assay, BDNF stimulation","journal":"The Journal of neuroscience","confidence":"High","confidence_rationale":"Tier 2 / Strong — reciprocal Co-IP, epistasis rescue experiments, in vivo knockdown, and BDNF-Rac1 activation assay across multiple methods and cellular contexts","pmids":["20861382"],"is_preprint":false},{"year":2011,"finding":"Extrasynaptic NMDA receptor activation induces nuclear-to-cytoplasmic translocation of endogenous CDKL5 in hippocampal neurons followed by proteasomal degradation; CDKL5 does not constitutively shuttle between nucleus and cytoplasm in post-mitotic neurons unlike in proliferating cells.","method":"Immunofluorescence in primary hippocampal neurons, glutamate/NMDA stimulation, proteasome inhibitor treatment, subcellular fractionation","journal":"The Journal of biological chemistry","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — direct localization imaging plus pharmacological dissection, single lab, multiple conditions","pmids":["21832092"],"is_preprint":false},{"year":2012,"finding":"CDKL5 loss-of-function in mice disrupts multiple signal transduction pathways including the AKT-mTOR cascade, as revealed by kinome profiling, and leads to autistic-like behavioral deficits.","method":"Cdkl5 knockout mouse, kinome profiling, behavioral analysis","journal":"Proceedings of the National Academy of Sciences of the United States of America","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — kinome profiling plus behavioral phenotyping in KO mouse, single lab","pmids":["23236174"],"is_preprint":false},{"year":2012,"finding":"CDKL5 overexpression in neuroblastoma cells causes G0/G1 cell cycle arrest and promotes differentiation; MYCN acts as a direct transcriptional repressor of the CDKL5 promoter, establishing a MYCN–CDKL5 axis governing neuronal proliferation and differentiation.","method":"Overexpression in neuroblastoma cells, flow cytometry, ChIP, promoter reporter assays, MYCN knockdown","journal":"Biochimica et biophysica acta","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — ChIP plus reporter assay plus flow cytometry, single lab, multiple methods","pmids":["22921766"],"is_preprint":false},{"year":2013,"finding":"CDKL5 binds directly to the scaffolding protein PSD-95 in a palmitoylation-dependent manner, and this interaction is required for synaptic targeting of CDKL5; pathogenic C-terminal truncation mutations reduce CDKL5–PSD-95 binding and synaptic accumulation; loss of CDKL5 or disruption of CDKL5–PSD-95 interaction inhibits dendritic spine formation and growth.","method":"Co-immunoprecipitation, palmitoylation manipulation, RNAi knockdown, overexpression, immunofluorescence","journal":"Proceedings of the National Academy of Sciences of the United States of America","confidence":"High","confidence_rationale":"Tier 2 / Strong — reciprocal Co-IP, palmitoylation manipulation, pathogenic mutant analysis, and RNAi spine phenotype, multiple orthogonal methods","pmids":["23671101"],"is_preprint":false},{"year":2014,"finding":"CDKL5 loss impairs AKT/GSK-3β signaling, reduces survival of newborn neurons, decreases total granule cell number in hippocampal dentate gyrus, and causes dendritic hypotrophy of newly generated granule cells.","method":"Cdkl5 knockout mouse, Western blotting for AKT/GSK-3β pathway, immunohistochemistry, BrdU labeling, behavioral testing","journal":"Neurobiology of disease","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — KO mouse with defined cellular phenotype and pathway analysis, single lab","pmids":["24952363"],"is_preprint":false},{"year":2014,"finding":"Loss of CDKL5 in cortical neurons reduces dendritic arborization; conditional knockout in excitatory versus inhibitory forebrain neurons maps behavioral phenotypes to separable cell types; Akt/rpS6 signaling is altered in CDKL5-deficient neurons.","method":"Conditional Cre-loxP knockout mice (excitatory and inhibitory neuron-specific), morphological analysis, EEG, behavioral testing, Western blotting","journal":"PloS one","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — cell-type-specific conditional KO with defined phenotypic readouts, single lab","pmids":["24838000"],"is_preprint":false},{"year":2015,"finding":"CDKL5 phosphorylates amphiphysin 1 (Amph1) at Ser-293, and substrate recognition requires an arginine at the P-3 position and a proline at P-2 (consensus RPXSX); the Amph2 CLAP domain contributes to efficient phosphorylation.","method":"In vitro kinase assay with Amph1/Amph2 mutants, site-directed mutagenesis, phosphorylation mapping","journal":"Biochemistry","confidence":"High","confidence_rationale":"Tier 1 / Moderate — in vitro kinase assay with systematic mutagenesis of substrate recognition motif, rigorous biochemical characterization","pmids":["25905439"],"is_preprint":false},{"year":2016,"finding":"CDKL5 interacts with and is phosphorylated at Ser-308 by DYRK1A; DYRK1A-mediated phosphorylation of CDKL5 at Ser-308 increases its cytoplasmic localization; phosphomimetic S308D mutation shifts CDKL5 to the cytosol while S308A keeps it nuclear.","method":"Co-immunoprecipitation, in vitro kinase assay, site-directed mutagenesis, immunofluorescence","journal":"Biochemical and biophysical research communications","confidence":"Medium","confidence_rationale":"Tier 1–2 / Moderate — in vitro kinase assay plus mutagenesis plus Co-IP, single lab","pmids":["27840050"],"is_preprint":false},{"year":2016,"finding":"CDKL5 interacts with shootin1 (a determinant of axon formation) in vivo; both proteins colocalize at the distal tip of outgrowing axons; CDKL5 loss disrupts neuronal polarization; CDKL5 overexpression generates supernumerary axons in a shootin1-dependent manner; shootin1 phosphorylation is reduced in CDKL5-silenced neurons.","method":"Yeast two-hybrid screening, Co-immunoprecipitation, immunofluorescence, RNAi knockdown, overexpression in hippocampal neurons","journal":"PloS one","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — reciprocal Co-IP plus in vivo neuronal localization plus RNAi epistasis, single lab","pmids":["26849555"],"is_preprint":false},{"year":2017,"finding":"CDKL5 deficiency in the hippocampus causes postsynaptic overaccumulation of GluN2B and SAP102, increased NMDA/AMPA ratio and prolonged NMDA-EPSC decay time; ifenprodil (GluN2B-selective antagonist) abrogates NMDA-induced hyperexcitability, indicating CDKL5 controls postsynaptic localization of the GluN2B–SAP102 complex.","method":"Cdkl5 knockout mouse, subcellular fractionation of PSD, immunoelectron microscopy, whole-cell patch clamp, pharmacological rescue","journal":"Neurobiology of disease","confidence":"High","confidence_rationale":"Tier 1–2 / Strong — subcellular fractionation, immunoEM, electrophysiology, and pharmacological rescue using multiple orthogonal methods","pmids":["28688852"],"is_preprint":false},{"year":2017,"finding":"CDKL5 localizes to the centrosome and midbody in proliferating cells; its depletion by RNAi causes multipolar spindle formation and cytokinesis failure; CDKL5-depleted midbodies lack HIPK2 and H2B-S14 phosphorylation; expression of phosphomimetic H2B-S14D rescues spindle multipolarity.","method":"Immunofluorescence, RNAi knockdown, rescue with H2B-S14D phosphomimetic, microscopy of mitotic cells","journal":"Scientific reports","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — direct localization plus RNAi phenotype plus functional rescue, single lab","pmids":["28740074"],"is_preprint":false},{"year":2018,"finding":"Using chemical genetics (analog-sensitive kinase approach), CDKL5 was found to directly phosphorylate three microtubule-associated proteins — MAP1S, EB2, and ARHGEF2 — at defined sites; phosphorylation of these substrates is reduced in CDKL5 knockout mice (confirming physiological relevance); CDKL5 phosphorylation of MAP1S promotes its dissociation from microtubules; loss of CDKL5 leads to longer EB3-labelled dendritic microtubule plus-end growth, rescued by MAP1S shRNA; anterograde cargo trafficking is impaired in CDKL5 KO dendrites.","method":"Chemical genetics (analog-sensitive kinase), mass spectrometry, phospho-specific antibodies, CDKL5 KO mice, live imaging of EB3, shRNA knockdown, cargo trafficking assay","journal":"The EMBO journal","confidence":"High","confidence_rationale":"Tier 1 / Strong — chemical genetic substrate identification plus in vivo validation in KO mice plus mechanistic rescue experiments, multiple orthogonal methods","pmids":["30266824"],"is_preprint":false},{"year":2018,"finding":"Quantitative phosphoproteomic screen identified MAP1S (pSer900), CEP131 (pSer35), and DLG5 as cellular substrates of CDKL5; the phospho-acceptor motif is RPXSA; pathogenic CDKL5 mutations cause major reduction of kinase activity in vitro and in cells.","method":"Quantitative phosphoproteomics (SILAC), phospho-specific antibodies, in vitro kinase assay with patient-derived mutants","journal":"The EMBO journal","confidence":"High","confidence_rationale":"Tier 1 / Strong — SILAC-based proteomics plus phospho-antibody validation plus in vitro kinase assay, multiple orthogonal methods, independent replication of MAP1S as substrate","pmids":["30266925"],"is_preprint":false},{"year":2018,"finding":"Cdkl5 deficiency in primary hippocampal neurons causes reduced GluA2 subunit expression, hyper-phosphorylation of GluA2-Ser880, increased GluA2 ubiquitination, and a shift to GluA2-lacking calcium-permeable AMPARs at the synapse.","method":"RNAi knockdown in neurons, Western blotting, immunoprecipitation, surface AMPAR immunofluorescence","journal":"Human molecular genetics","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — biochemical characterization with multiple endpoints, single lab","pmids":["29618004"],"is_preprint":false},{"year":2019,"finding":"SMAD3 is a direct phosphorylation target of CDKL5; CDKL5-dependent phosphorylation stabilizes SMAD3 protein; CDKL5-deficient neurons show reduced SMAD3 signaling and are more vulnerable to excitotoxic stimuli; TGF-β1 treatment normalizes defective neuronal survival in Cdkl5 KO neurons and prevents NMDA-induced cell death in vivo.","method":"In vitro kinase assay, Western blotting in KO neurons, TGF-β1 rescue experiments in vitro and in vivo","journal":"Brain pathology","confidence":"Medium","confidence_rationale":"Tier 1–2 / Moderate — in vitro kinase assay plus KO neuronal phenotype plus in vivo rescue, single lab","pmids":["30793413"],"is_preprint":false},{"year":2019,"finding":"Selective loss of CDKL5 in GABAergic neurons leads to autistic-like phenotypes in mice with excessive glutamatergic transmission, hyperexcitability, and increased postsynaptic NMDA receptors; acute low-dose NMDA receptor inhibition ameliorates autistic-like behaviors in GABAergic-specific and R59X knockin CDKL5 mice.","method":"Conditional GABAergic-specific Cre-lox KO, behavioral testing, electrophysiology, pharmacological rescue with NMDAR antagonist, knockin mouse model","journal":"Nature communications","confidence":"High","confidence_rationale":"Tier 2 / Strong — cell-type specific KO plus electrophysiology plus pharmacological rescue, replicated in second model (R59X knockin)","pmids":["31201320"],"is_preprint":false},{"year":2020,"finding":"CDKL5 is a stress-responsive kinase in renal tubular epithelial cells that promotes cell death through phosphorylation-dependent suppression of the pro-survival transcription factor SOX9; genetic or pharmacological Cdkl5 inhibition protects against nephrotoxic and ischemia-associated acute kidney injury in mouse models.","method":"Kinome-wide RNAi screen, conditional Cdkl5 gene ablation in RTECs, kinase assay with SOX9, pharmacological inhibition (AST-487), mouse AKI models","journal":"Nature communications","confidence":"High","confidence_rationale":"Tier 1–2 / Strong — in vitro kinase assay for SOX9 phosphorylation, cell-type-specific KO, pharmacological inhibition, replicated across two AKI models","pmids":["32317630"],"is_preprint":false},{"year":2021,"finding":"CDKL5 is recruited to sites of DNA damage in actively transcribed regions; a nuclear phosphoproteomic screen identified Elongin A (ELOA) as a CDKL5 substrate phosphorylated on a CDKL5 consensus motif; CDKL5 recruitment and ELOA phosphorylation require active transcription and poly(ADP-ribose) (PAR) synthesis, to which CDKL5 can bind; CDKL5 kinase activity is essential for transcriptional silencing at sites of DNA double-strand breaks.","method":"Quantitative nuclear phosphoproteomics, PAR binding assay, recruitment to DNA damage sites by imaging, transcription inhibition experiments, kinase-dead mutant analysis","journal":"The EMBO journal","confidence":"High","confidence_rationale":"Tier 1–2 / Strong — nuclear phosphoproteomics plus PAR binding plus localization imaging plus kinase-dead functional analysis, multiple orthogonal methods","pmids":["34605059"],"is_preprint":false},{"year":2021,"finding":"Postdevelopmental (adult-stage) loss of CDKL5 disrupts behavioral domains, hippocampal circuit communication, and dendritic spine morphology; restoration of Cdkl5 expression after early brain development ameliorates CDD-related behavioral impairments and aberrant NMDA receptor signaling, demonstrating that CDKL5 function is required beyond early development.","method":"Temporal conditional knockout and rescue mouse models (inducible Cre), behavioral testing, electrophysiology, dendritic spine morphology analysis","journal":"The Journal of clinical investigation","confidence":"High","confidence_rationale":"Tier 2 / Strong — temporal KO and conditional rescue experiments with behavioral and electrophysiological phenotyping, orthogonal methods","pmids":["34651584"],"is_preprint":false},{"year":2021,"finding":"CDKL5 deficiency in glutamatergic (Emx1- or CamK2α-Cre) but not GABAergic neurons generates high-frequency spontaneous recurrent seizures, accompanied by hippocampal mossy fiber sprouting and increased excitatory synaptic activity (higher frequency but unchanged amplitude of sEPSCs and mEPSCs in dentate granule cells).","method":"Cell-type-specific conditional KO (Emx1-Cre, CamK2α-Cre, GAD-Cre), in vivo EEG/video, Timm staining for mossy fiber sprouting, whole-cell patch clamp","journal":"Epilepsia","confidence":"High","confidence_rationale":"Tier 2 / Strong — multiple cell-type-specific KO lines, in vivo electrophysiology, morphological analysis, and patch clamp, multiple orthogonal methods","pmids":["33400301"],"is_preprint":false},{"year":2023,"finding":"CDKL5 directly phosphorylates the voltage-gated calcium channel Cav2.3 (CACNA1E); loss of Cav2.3 phosphorylation leads to channel gain-of-function via slower inactivation and enhanced cholinergic stimulation, increasing neuronal excitability; CDD is therefore partly a channelopathy sharing mechanistic features with CACNA1E gain-of-function DEE69.","method":"SILAC phosphoproteomic screen, recombinant channel electrophysiology, Cav2.3 phosphomutant knockin mice, CDKL5 KO mice, neuronal excitability recordings","journal":"Nature communications","confidence":"High","confidence_rationale":"Tier 1 / Strong — phosphoproteomic identification plus recombinant electrophysiology plus in vivo phosphomutant mouse, multiple orthogonal methods","pmids":["38081835"],"is_preprint":false},{"year":2023,"finding":"CDKL5 is selectively required for efficient synaptic vesicle (SV) endocytosis in hippocampal neurons; the isolated CDKL5 kinase domain fully restores SV endocytosis kinetics in KO neurons; kinase-inactive CDKL5 mutations fail to rescue endocytosis; phosphorylation of amphiphysin 1 by CDKL5 is not required for SV endocytosis (negative finding for Amph1 as presynaptic effector of endocytosis).","method":"Cdkl5 knockout rat hippocampal neurons, genetically encoded SV reporter, kinase-dead and domain-deletion constructs, rescue experiments","journal":"The Journal of neuroscience","confidence":"High","confidence_rationale":"Tier 1–2 / Moderate — functional reporter assay plus kinase-dead mutagenesis plus domain rescue experiments, multiple orthogonal approaches","pmids":["36759195"],"is_preprint":false},{"year":2024,"finding":"CDKL5 and EB2 phosphorylation (pS222) are prominent in excitatory and inhibitory neurons but absent in astrocytes; ~15–20% residual EB2 pS222 persists in neuronal CDKL5 KO, regulated by NMDA and PP1/PP2A; CDKL2 and ICK can phosphorylate EB2-S222 in vitro; dual Cdkl5/Cdkl2 KO mice confirm that CDKL2 compensates CDKL5 substrate phosphorylation in vivo.","method":"Cell-type-specific conditional KO mice, phospho-specific antibody for EB2 pS222, kinase screen in HEK293T cells, dual KO mice","journal":"Molecular psychiatry","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — conditional KO with validated phospho-antibody plus in vitro kinase screen plus dual KO validation, single lab","pmids":["38326557"],"is_preprint":false},{"year":2024,"finding":"CDKL5 directly binds the selective autophagy receptor p62 and phosphorylates p62 at T269/S272; CDKL5-mediated p62 phosphorylation promotes large p62 inclusion body formation that captures viral capsids, initiating virophagy; CDKL5 deficiency reduces clearance of Sindbis virus capsid aggregates and increases neuronal cell death after neurotropic virus infection.","method":"Co-immunoprecipitation, in vitro kinase assay with p62 mutants, Cdkl5 KO mice infected with neurotropic viruses, imaging of p62 inclusion bodies","journal":"The Journal of clinical investigation","confidence":"High","confidence_rationale":"Tier 1–2 / Strong — in vitro kinase assay plus Co-IP plus in vivo KO mouse virophagy phenotype, multiple orthogonal methods","pmids":["37917202"],"is_preprint":false}],"current_model":"CDKL5 is a brain-enriched serine/threonine kinase whose catalytic activity — regulated by C-terminal domain-mediated autoinhibition and DYRK1A-dependent phosphorylation at Ser-308 — is required for multiple neuronal functions including dendritic arborization via Rac1 signaling, synaptic maturation via PSD-95-dependent targeting and GluN2B/AMPAR regulation, dendritic microtubule dynamics via phosphorylation of MAP1S/EB2/ARHGEF2, axonal specification via shootin1 interaction, synaptic vesicle endocytosis, transcription-coupled DNA damage responses via Elongin A phosphorylation, and regulation of neuronal excitability through Cav2.3 channel phosphorylation; it also phosphorylates MeCP2, SMAD3, CEP131, DLG5, and p62 (the last regulating virophagy), and is itself transcriptionally repressed by MeCP2 binding to its methylated promoter and by MYCN."},"narrative":{"mechanistic_narrative":"CDKL5 is a brain-enriched serine/threonine kinase that governs neuronal maturation, synaptic function, and excitability through phosphorylation of an expanding set of cytoskeletal, synaptic, and nuclear substrates [PMID:20861382, PMID:30266824, PMID:38081835]. Its catalytic activity is intrinsically autoinhibited by its C-terminal domain, which also controls nucleocytoplasmic distribution: C-terminal truncation enhances autophosphorylation and shifts the kinase between nucleus and cytoplasm, and DYRK1A-mediated phosphorylation at Ser-308 promotes cytoplasmic localization [PMID:16330482, PMID:18701457, PMID:27840050]. CDKL5 recognizes substrates through an RPXS(A) consensus motif and phosphorylates the microtubule regulators MAP1S, EB2, and ARHGEF2 to control dendritic microtubule plus-end dynamics and cargo trafficking, the centrosomal protein CEP131, and DLG5 [PMID:25905439, PMID:30266824, PMID:30266925]. In neurons it drives dendritic arborization and spine formation via a Rac1 complex and BDNF-dependent Rac1 activation, and via palmitoylation-dependent binding to PSD-95 that targets it to synapses [PMID:20861382, PMID:23671101]. CDKL5 controls excitatory signaling by restraining postsynaptic GluN2B–SAP102 NMDA receptors and GluA2-containing AMPARs, and by phosphorylating the Cav2.3 (CACNA1E) calcium channel, such that its loss produces a partial channelopathy and hyperexcitability [PMID:28688852, PMID:29618004, PMID:38081835]. Beyond development, CDKL5 phosphorylates SMAD3 to support neuronal survival, mediates synaptic vesicle endocytosis through its kinase domain, is recruited via poly(ADP-ribose) to transcription-coupled DNA damage sites where it phosphorylates Elongin A to enable transcriptional silencing, and phosphorylates p62 to initiate virophagy [PMID:30793413, PMID:34605059, PMID:36759195, PMID:37917202]. CDKL5 also physically interacts with and is in a common pathway with MeCP2, which transcriptionally represses Cdkl5 by binding its methylated promoter, while MYCN represses CDKL5 in proliferating cells [PMID:15917271, PMID:20211261, PMID:22921766]. Restoring CDKL5 after early development reverses behavioral and NMDA receptor signaling deficits, establishing an ongoing adult requirement [PMID:34651584].","teleology":[{"year":2005,"claim":"Establishing CDKL5 as an active kinase physically and functionally linked to MeCP2 placed it within the Rett-spectrum disorder pathway and gave it a candidate substrate.","evidence":"Co-IP and in vitro kinase assays in brain and cell systems","pmids":["15917271","15499549"],"confidence":"High","gaps":["A later study failed to confirm direct MeCP2 phosphorylation","Physiological consequences of MeCP2 phosphorylation not defined"]},{"year":2006,"claim":"Identifying C-terminal autoinhibition, TEY-motif autophosphorylation, and self-association defined how CDKL5 catalytic output and localization are intrinsically regulated.","evidence":"In vitro kinase assays, mutagenesis, Co-IP, and fractionation/immunofluorescence","pmids":["16330482","16935860"],"confidence":"High","gaps":["Structural basis of autoinhibition unresolved","Trigger that relieves autoinhibition in vivo unknown"]},{"year":2008,"claim":"Demonstrating C-terminus-dependent nuclear export and developmental shuttling explained how Rett truncations cause aberrant nuclear accumulation.","evidence":"Brain immunostaining, fractionation, truncation constructs, nuclear export inhibition","pmids":["18701457","19740913"],"confidence":"High","gaps":["Export receptor/NES not mapped","Functional role of nuclear speckle localization unclear"]},{"year":2010,"claim":"Showing CDKL5 forms a Rac1 complex required for BDNF-induced Rac1 activation and dendritic growth gave the kinase its first concrete neuronal morphogenesis role.","evidence":"RNAi, in utero electroporation, Co-IP, Rac1 activation assay, epistasis rescue","pmids":["20861382","20211261"],"confidence":"High","gaps":["Direct Rac1 GEF/effector phosphorylated by CDKL5 not identified here","Whether Rac1 regulation requires kinase activity not fully resolved"]},{"year":2012,"claim":"Knockout kinome profiling and the MYCN repression axis connected CDKL5 loss to AKT-mTOR signaling and to control of neuronal proliferation/differentiation.","evidence":"Cdkl5 KO mouse kinome profiling, behavior; neuroblastoma overexpression, ChIP, reporter assays","pmids":["23236174","22921766"],"confidence":"Medium","gaps":["Direct CDKL5 substrates in the AKT-mTOR cascade not identified","Mechanism linking kinase activity to cell-cycle arrest unknown"]},{"year":2013,"claim":"Identifying palmitoylation-dependent PSD-95 binding as the synaptic targeting mechanism explained how pathogenic C-terminal truncations impair spine formation.","evidence":"Co-IP, palmitoylation manipulation, RNAi spine phenotype, pathogenic mutant analysis","pmids":["23671101"],"confidence":"High","gaps":["Whether PSD-95 is a CDKL5 substrate not established","Kinase targets at the synapse not defined here"]},{"year":2015,"claim":"Defining the RPXSX substrate consensus through amphiphysin 1 phosphorylation provided the rule for predicting and validating CDKL5 substrates.","evidence":"In vitro kinase assays with Amph1/Amph2 mutants and motif mutagenesis","pmids":["25905439"],"confidence":"High","gaps":["Physiological role of Amph1-Ser293 phosphorylation later questioned","Cellular context of phosphorylation not addressed"]},{"year":2016,"claim":"DYRK1A phosphorylation at Ser-308 and shootin1 interaction extended CDKL5 regulation to upstream control of localization and to axon specification.","evidence":"Co-IP, in vitro kinase assay, phosphomimetic mutants; yeast two-hybrid, RNAi epistasis in neurons","pmids":["27840050","26849555"],"confidence":"Medium","gaps":["Whether shootin1 is a direct CDKL5 substrate not firmly established","In vivo significance of Ser-308 phosphorylation untested"]},{"year":2017,"claim":"Showing CDKL5 restrains postsynaptic GluN2B-SAP102 NMDA receptors and functions at the centrosome/midbody revealed both synaptic excitability control and a mitotic role.","evidence":"KO mouse PSD fractionation, immunoEM, patch clamp, pharmacological rescue; RNAi and H2B-S14D rescue in mitotic cells","pmids":["28688852","28740074"],"confidence":"High","gaps":["Direct NMDA receptor substrate not identified","Relationship between mitotic and neuronal functions unclear"]},{"year":2018,"claim":"Unbiased chemical-genetic and phosphoproteomic substrate identification established MAP1S, EB2, ARHGEF2, CEP131, and DLG5 as physiological substrates linking CDKL5 to microtubule dynamics and cargo trafficking.","evidence":"Analog-sensitive kinase, SILAC phosphoproteomics, phospho-antibodies, KO mice, live EB3 imaging, rescue","pmids":["30266824","30266925","29618004"],"confidence":"High","gaps":["How substrate phosphorylation maps onto disease phenotypes incompletely defined","AMPAR GluA2 regulation mechanism partly correlative"]},{"year":2019,"claim":"SMAD3 phosphorylation and GABAergic-specific loss-of-function linked CDKL5 to neuronal survival and to NMDA-receptor-dependent autistic-like behaviors amenable to pharmacological rescue.","evidence":"In vitro kinase assay, KO neuron survival, TGF-β1 rescue; GABAergic conditional and R59X knockin mice with NMDAR antagonist rescue","pmids":["30793413","31201320"],"confidence":"High","gaps":["Direct SMAD3 phospho-site not detailed in narrative-relevant terms","Cell-type-specific substrate basis of behavior unresolved"]},{"year":2020,"claim":"Discovery of CDKL5 as a stress-responsive pro-death kinase phosphorylating SOX9 in renal epithelium revealed a function outside the nervous system.","evidence":"Kinome RNAi screen, RTEC conditional KO, SOX9 kinase assay, pharmacological inhibition, AKI mouse models","pmids":["32317630"],"confidence":"High","gaps":["Whether SOX9 regulation occurs in neurons unknown","Tissue-specific determinants of CDKL5 pro-death versus pro-survival roles unclear"]},{"year":2021,"claim":"Identifying transcription-coupled, PAR-dependent recruitment to DNA damage sites with Elongin A phosphorylation, plus demonstrating an adult requirement, redefined CDKL5 as both a genome-protective nuclear kinase and a persistently required regulator.","evidence":"Nuclear phosphoproteomics, PAR binding, DNA damage recruitment imaging, kinase-dead analysis; temporal KO/rescue mice with behavior and electrophysiology; cell-type KO seizure models","pmids":["34605059","34651584","33400301"],"confidence":"High","gaps":["How nuclear DNA-damage role relates to synaptic functions unknown","Glutamatergic versus GABAergic substrate differences not molecularly resolved"]},{"year":2023,"claim":"Establishing Cav2.3 as a direct substrate and the kinase domain alone as sufficient for synaptic vesicle endocytosis tied CDKL5 to neuronal excitability as a partial channelopathy and to presynaptic membrane trafficking.","evidence":"SILAC phosphoproteomics, recombinant electrophysiology, phosphomutant knockin mice; SV reporter assays with kinase-dead and domain constructs","pmids":["38081835","36759195"],"confidence":"High","gaps":["Endocytosis substrate distinct from amphiphysin 1 not identified","Contribution of Cav2.3 to overall CDD phenotype quantitatively undefined"]},{"year":2024,"claim":"Defining p62 phosphorylation in virophagy and CDKL2 compensation of EB2 phosphorylation expanded CDKL5 function to selective autophagy and revealed kinase redundancy in vivo.","evidence":"Co-IP, p62 mutant kinase assays, neurotropic virus KO mice; cell-type KO with phospho-antibody, in vitro kinase screen, dual Cdkl5/Cdkl2 KO mice","pmids":["37917202","38326557"],"confidence":"High","gaps":["Extent of CDKL2 compensation across substrates unknown","Whether virophagy defect contributes to CDD pathology untested"]},{"year":null,"claim":"How CDKL5's many substrates and subcellular roles are coordinately deployed across cell types and developmental stages to produce its disease phenotype remains unresolved.","evidence":"","pmids":[],"confidence":"Medium","gaps":["No structural model of CDKL5 substrate engagement or autoinhibition","Hierarchy and relative phenotypic weight of substrates undefined","Mechanisms governing spatial partitioning between nuclear and synaptic functions unknown"]}],"mechanism_profile":{"molecular_activity":[{"term_id":"GO:0140096","term_label":"catalytic activity, acting on a protein","supporting_discovery_ids":[0,16,21,22,24,26,27,30,33]},{"term_id":"GO:0016740","term_label":"transferase activity","supporting_discovery_ids":[0,16,21,22,30]},{"term_id":"GO:0140657","term_label":"ATP-dependent activity","supporting_discovery_ids":[16,21,22]}],"localization":[{"term_id":"GO:0005634","term_label":"nucleus","supporting_discovery_ids":[1,3,6,27]},{"term_id":"GO:0005829","term_label":"cytosol","supporting_discovery_ids":[3,6,17]},{"term_id":"GO:0005886","term_label":"plasma membrane","supporting_discovery_ids":[13,19]},{"term_id":"GO:0005815","term_label":"microtubule organizing center","supporting_discovery_ids":[20]},{"term_id":"GO:0005654","term_label":"nucleoplasm","supporting_discovery_ids":[7]}],"pathway":[{"term_id":"R-HSA-112316","term_label":"Neuronal System","supporting_discovery_ids":[9,13,19,29,30]},{"term_id":"R-HSA-162582","term_label":"Signal Transduction","supporting_discovery_ids":[9,11,24]},{"term_id":"R-HSA-73894","term_label":"DNA Repair","supporting_discovery_ids":[27]},{"term_id":"R-HSA-9612973","term_label":"Autophagy","supporting_discovery_ids":[33]},{"term_id":"R-HSA-5653656","term_label":"Vesicle-mediated transport","supporting_discovery_ids":[31]},{"term_id":"R-HSA-1640170","term_label":"Cell Cycle","supporting_discovery_ids":[20]}],"complexes":[],"partners":["MECP2","RAC1","DLG4","DYRK1A","SHTN1","EB2","SQSTM1"],"other_free_text":[]}},"prefetch_data":{"uniprot":{"accession":"O76039","full_name":"Cyclin-dependent kinase-like 5","aliases":["Serine/threonine-protein kinase 9"],"length_aa":960,"mass_kda":107.5,"function":"Mediates phosphorylation of MECP2 (PubMed:15917271, PubMed:16935860). May regulate ciliogenesis (PubMed:29420175)","subcellular_location":"Nucleus; Cytoplasm, cytoskeleton, cilium basal body; Cytoplasm, cytoskeleton, microtubule organizing center, centrosome","url":"https://www.uniprot.org/uniprotkb/O76039/entry"},"depmap":{"release":"DepMap","has_data":true,"is_common_essential":false,"resolved_as":"","url":"https://depmap.org/portal/gene/CDKL5","classification":"Not Classified","n_dependent_lines":0,"n_total_lines":1208,"dependency_fraction":0.0},"opencell":{"profiled":false,"resolved_as":"","ensg_id":"","cell_line_id":"","localizations":[],"interactors":[],"url":"https://opencell.sf.czbiohub.org/search/CDKL5","total_profiled":1310},"omim":[{"mim_id":"613443","title":"NEURODEVELOPMENTAL DISORDER WITH HYPOTONIA, STEREOTYPIC HAND MOVEMENTS, AND IMPAIRED LANGUAGE; NEDHSIL","url":"https://www.omim.org/entry/613443"},{"mim_id":"608818","title":"NETRIN G1; NTNG1","url":"https://www.omim.org/entry/608818"},{"mim_id":"608459","title":"CYCLIN-DEPENDENT KINASE-LIKE 3; CDKL3","url":"https://www.omim.org/entry/608459"},{"mim_id":"603442","title":"CYCLIN-DEPENDENT KINASE-LIKE 2; CDKL2","url":"https://www.omim.org/entry/603442"},{"mim_id":"603441","title":"CYCLIN-DEPENDENT KINASE-LIKE 1; CDKL1","url":"https://www.omim.org/entry/603441"}],"hpa":{"profiled":true,"resolved_as":"","reliability":"Supported","locations":[{"location":"Nucleoplasm","reliability":"Supported"}],"tissue_specificity":"Tissue enhanced","tissue_distribution":"Detected in all","driving_tissues":[{"tissue":"brain","ntpm":12.8}],"url":"https://www.proteinatlas.org/search/CDKL5"},"hgnc":{"alias_symbol":["EIEE2","CFAP247"],"prev_symbol":["STK9"]},"alphafold":{"accession":"O76039","domains":[{"cath_id":"3.30.200.20","chopping":"2-92","consensus_level":"medium","plddt":82.8441,"start":2,"end":92},{"cath_id":"1.10.510.10","chopping":"94-303","consensus_level":"high","plddt":92.4732,"start":94,"end":303}],"viewer_url":"https://alphafold.ebi.ac.uk/entry/O76039","model_url":"https://alphafold.ebi.ac.uk/files/AF-O76039-F1-model_v6.cif","pae_url":"https://alphafold.ebi.ac.uk/files/AF-O76039-F1-predicted_aligned_error_v6.png","plddt_mean":53.12},"mouse_models":{"mgi_url":"https://www.informatics.jax.org/marker/summary?nomen=CDKL5","jax_strain_url":"https://www.jax.org/strain/search?query=CDKL5"},"sequence":{"accession":"O76039","fasta_url":"https://rest.uniprot.org/uniprotkb/O76039.fasta","uniprot_url":"https://www.uniprot.org/uniprotkb/O76039/entry","alphafold_viewer_url":"https://alphafold.ebi.ac.uk/entry/O76039"}},"corpus_meta":[{"pmid":"15917271","id":"PMC_15917271","title":"CDKL5 belongs to the same molecular pathway of MeCP2 and it is responsible for the early-onset seizure variant of Rett syndrome.","date":"2005","source":"Human molecular genetics","url":"https://pubmed.ncbi.nlm.nih.gov/15917271","citation_count":255,"is_preprint":false},{"pmid":"15499549","id":"PMC_15499549","title":"Mutations in the X-linked cyclin-dependent kinase-like 5 (CDKL5/STK9) gene are associated with severe neurodevelopmental retardation.","date":"2004","source":"American journal of human genetics","url":"https://pubmed.ncbi.nlm.nih.gov/15499549","citation_count":244,"is_preprint":false},{"pmid":"22872100","id":"PMC_22872100","title":"The CDKL5 disorder is an independent clinical entity associated with early-onset encephalopathy.","date":"2012","source":"European journal of human genetics : EJHG","url":"https://pubmed.ncbi.nlm.nih.gov/22872100","citation_count":227,"is_preprint":false},{"pmid":"15689447","id":"PMC_15689447","title":"CDKL5/STK9 is mutated in Rett syndrome variant with infantile spasms.","date":"2005","source":"Journal of medical genetics","url":"https://pubmed.ncbi.nlm.nih.gov/15689447","citation_count":185,"is_preprint":false},{"pmid":"23236174","id":"PMC_23236174","title":"Loss of CDKL5 disrupts kinome profile and event-related potentials leading to autistic-like phenotypes in mice.","date":"2012","source":"Proceedings of the National Academy of Sciences of the United States of America","url":"https://pubmed.ncbi.nlm.nih.gov/23236174","citation_count":180,"is_preprint":false},{"pmid":"18701457","id":"PMC_18701457","title":"CDKL5 expression is modulated during neuronal development and its subcellular distribution is tightly regulated by the C-terminal tail.","date":"2008","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/18701457","citation_count":172,"is_preprint":false},{"pmid":"24838000","id":"PMC_24838000","title":"Mapping pathological phenotypes in a mouse model of CDKL5 disorder.","date":"2014","source":"PloS one","url":"https://pubmed.ncbi.nlm.nih.gov/24838000","citation_count":156,"is_preprint":false},{"pmid":"20861382","id":"PMC_20861382","title":"CDKL5, a protein associated with rett syndrome, regulates neuronal morphogenesis via Rac1 signaling.","date":"2010","source":"The Journal of neuroscience : the official journal of the Society for Neuroscience","url":"https://pubmed.ncbi.nlm.nih.gov/20861382","citation_count":154,"is_preprint":false},{"pmid":"16015284","id":"PMC_16015284","title":"Early onset seizures and Rett-like features associated with mutations in CDKL5.","date":"2005","source":"European journal of human genetics : EJHG","url":"https://pubmed.ncbi.nlm.nih.gov/16015284","citation_count":134,"is_preprint":false},{"pmid":"16935860","id":"PMC_16935860","title":"Functional consequences of mutations in CDKL5, an X-linked gene involved in infantile spasms and mental retardation.","date":"2006","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/16935860","citation_count":132,"is_preprint":false},{"pmid":"31313283","id":"PMC_31313283","title":"CDKL5 deficiency disorder: Relationship between genotype, epilepsy, cortical visual impairment, and development.","date":"2019","source":"Epilepsia","url":"https://pubmed.ncbi.nlm.nih.gov/31313283","citation_count":127,"is_preprint":false},{"pmid":"22998673","id":"PMC_22998673","title":"Epilepsy in Rett syndrome, and CDKL5- and FOXG1-gene-related encephalopathies.","date":"2012","source":"Epilepsia","url":"https://pubmed.ncbi.nlm.nih.gov/22998673","citation_count":120,"is_preprint":false},{"pmid":"24952363","id":"PMC_24952363","title":"Loss of CDKL5 impairs survival and dendritic growth of newborn neurons by altering AKT/GSK-3β signaling.","date":"2014","source":"Neurobiology of disease","url":"https://pubmed.ncbi.nlm.nih.gov/24952363","citation_count":111,"is_preprint":false},{"pmid":"27080038","id":"PMC_27080038","title":"Prevalence and onset of comorbidities in the CDKL5 disorder differ from Rett syndrome.","date":"2016","source":"Orphanet journal of rare diseases","url":"https://pubmed.ncbi.nlm.nih.gov/27080038","citation_count":110,"is_preprint":false},{"pmid":"16330482","id":"PMC_16330482","title":"CDKL5/Stk9 kinase inactivation is associated with neuronal developmental disorders.","date":"2005","source":"Human molecular genetics","url":"https://pubmed.ncbi.nlm.nih.gov/16330482","citation_count":104,"is_preprint":false},{"pmid":"28688852","id":"PMC_28688852","title":"CDKL5 controls postsynaptic localization of GluN2B-containing NMDA receptors in the hippocampus and regulates seizure susceptibility.","date":"2017","source":"Neurobiology of disease","url":"https://pubmed.ncbi.nlm.nih.gov/28688852","citation_count":102,"is_preprint":false},{"pmid":"23671101","id":"PMC_23671101","title":"Palmitoylation-dependent CDKL5-PSD-95 interaction regulates synaptic targeting of CDKL5 and dendritic spine development.","date":"2013","source":"Proceedings of the National Academy of Sciences of the United States of America","url":"https://pubmed.ncbi.nlm.nih.gov/23671101","citation_count":96,"is_preprint":false},{"pmid":"22779007","id":"PMC_22779007","title":"What we know and would like to know about CDKL5 and its involvement in epileptic encephalopathy.","date":"2012","source":"Neural plasticity","url":"https://pubmed.ncbi.nlm.nih.gov/22779007","citation_count":88,"is_preprint":false},{"pmid":"27770071","id":"PMC_27770071","title":"Seizure variables and their relationship to genotype and functional abilities in the CDKL5 disorder.","date":"2016","source":"Neurology","url":"https://pubmed.ncbi.nlm.nih.gov/27770071","citation_count":86,"is_preprint":false},{"pmid":"20211261","id":"PMC_20211261","title":"CDKL5 is a brain MeCP2 target gene regulated by DNA methylation.","date":"2010","source":"Neurobiology of disease","url":"https://pubmed.ncbi.nlm.nih.gov/20211261","citation_count":84,"is_preprint":false},{"pmid":"19793311","id":"PMC_19793311","title":"Mutational spectrum of CDKL5 in early-onset encephalopathies: a study of a large collection of French patients and review of the literature.","date":"2009","source":"Clinical genetics","url":"https://pubmed.ncbi.nlm.nih.gov/19793311","citation_count":84,"is_preprint":false},{"pmid":"27528505","id":"PMC_27528505","title":"Functional abilities in children and adults with the CDKL5 disorder.","date":"2016","source":"American journal of medical genetics. Part A","url":"https://pubmed.ncbi.nlm.nih.gov/27528505","citation_count":79,"is_preprint":false},{"pmid":"30246934","id":"PMC_30246934","title":"Molecular and Synaptic Bases of CDKL5 Disorder.","date":"2018","source":"Developmental neurobiology","url":"https://pubmed.ncbi.nlm.nih.gov/30246934","citation_count":77,"is_preprint":false},{"pmid":"21750574","id":"PMC_21750574","title":"iPS cells to model CDKL5-related disorders.","date":"2011","source":"European journal of human genetics : EJHG","url":"https://pubmed.ncbi.nlm.nih.gov/21750574","citation_count":73,"is_preprint":false},{"pmid":"30266824","id":"PMC_30266824","title":"Chemical genetic identification of CDKL5 substrates reveals its role in neuronal microtubule dynamics.","date":"2018","source":"The EMBO journal","url":"https://pubmed.ncbi.nlm.nih.gov/30266824","citation_count":72,"is_preprint":false},{"pmid":"32079229","id":"PMC_32079229","title":"CDKL5 Deficiency Disorder-A Complex Epileptic Encephalopathy.","date":"2020","source":"Brain sciences","url":"https://pubmed.ncbi.nlm.nih.gov/32079229","citation_count":71,"is_preprint":false},{"pmid":"23283985","id":"PMC_23283985","title":"CDKL5 regulates flagellar length and localizes to the base of the flagella in Chlamydomonas.","date":"2013","source":"Molecular biology of the cell","url":"https://pubmed.ncbi.nlm.nih.gov/23283985","citation_count":69,"is_preprint":false},{"pmid":"30266825","id":"PMC_30266825","title":"Phosphoproteomic screening identifies physiological substrates of the CDKL5 kinase.","date":"2018","source":"The EMBO journal","url":"https://pubmed.ncbi.nlm.nih.gov/30266825","citation_count":67,"is_preprint":false},{"pmid":"29264392","id":"PMC_29264392","title":"CDKL5 variants: Improving our understanding of a rare neurologic disorder.","date":"2017","source":"Neurology. Genetics","url":"https://pubmed.ncbi.nlm.nih.gov/29264392","citation_count":62,"is_preprint":false},{"pmid":"31201320","id":"PMC_31201320","title":"Altered NMDAR signaling underlies autistic-like features in mouse models of CDKL5 deficiency disorder.","date":"2019","source":"Nature communications","url":"https://pubmed.ncbi.nlm.nih.gov/31201320","citation_count":62,"is_preprint":false},{"pmid":"21309761","id":"PMC_21309761","title":"CDKL5 gene-related epileptic encephalopathy: electroclinical findings in the first year of life.","date":"2011","source":"Developmental medicine and child neurology","url":"https://pubmed.ncbi.nlm.nih.gov/21309761","citation_count":62,"is_preprint":false},{"pmid":"21770923","id":"PMC_21770923","title":"CDKL5 alterations lead to early epileptic encephalopathy in both genders.","date":"2011","source":"Epilepsia","url":"https://pubmed.ncbi.nlm.nih.gov/21770923","citation_count":61,"is_preprint":false},{"pmid":"27315173","id":"PMC_27315173","title":"Characterisation of CDKL5 Transcript Isoforms in Human and Mouse.","date":"2016","source":"PloS one","url":"https://pubmed.ncbi.nlm.nih.gov/27315173","citation_count":60,"is_preprint":false},{"pmid":"31147226","id":"PMC_31147226","title":"Severity Assessment in CDKL5 Deficiency Disorder.","date":"2019","source":"Pediatric neurology","url":"https://pubmed.ncbi.nlm.nih.gov/31147226","citation_count":59,"is_preprint":false},{"pmid":"26236424","id":"PMC_26236424","title":"Cytokine Dysregulation in MECP2- and CDKL5-Related Rett Syndrome: Relationships with Aberrant Redox Homeostasis, Inflammation, and ω-3 PUFAs.","date":"2015","source":"Oxidative medicine and cellular longevity","url":"https://pubmed.ncbi.nlm.nih.gov/26236424","citation_count":59,"is_preprint":false},{"pmid":"30952813","id":"PMC_30952813","title":"AMPA Receptor Dysregulation and Therapeutic Interventions in a Mouse Model of CDKL5 Deficiency Disorder.","date":"2019","source":"The Journal of neuroscience : the official journal of the Society for Neuroscience","url":"https://pubmed.ncbi.nlm.nih.gov/30952813","citation_count":57,"is_preprint":false},{"pmid":"29474534","id":"PMC_29474534","title":"CDKL5 protein substitution therapy rescues neurological phenotypes of a mouse model of CDKL5 disorder.","date":"2018","source":"Human molecular genetics","url":"https://pubmed.ncbi.nlm.nih.gov/29474534","citation_count":57,"is_preprint":false},{"pmid":"19241098","id":"PMC_19241098","title":"Novel mutations in the CDKL5 gene, predicted effects and associated phenotypes.","date":"2009","source":"Neurogenetics","url":"https://pubmed.ncbi.nlm.nih.gov/19241098","citation_count":57,"is_preprint":false},{"pmid":"34651584","id":"PMC_34651584","title":"Temporal manipulation of Cdkl5 reveals essential postdevelopmental functions and reversible CDKL5 deficiency disorder-related deficits.","date":"2021","source":"The Journal of clinical investigation","url":"https://pubmed.ncbi.nlm.nih.gov/34651584","citation_count":53,"is_preprint":false},{"pmid":"32317630","id":"PMC_32317630","title":"A kinome-wide screen identifies a CDKL5-SOX9 regulatory axis in epithelial cell death and kidney injury.","date":"2020","source":"Nature communications","url":"https://pubmed.ncbi.nlm.nih.gov/32317630","citation_count":53,"is_preprint":false},{"pmid":"19740913","id":"PMC_19740913","title":"CDKL5 influences RNA splicing activity by its association to the nuclear speckle molecular machinery.","date":"2009","source":"Human molecular genetics","url":"https://pubmed.ncbi.nlm.nih.gov/19740913","citation_count":53,"is_preprint":false},{"pmid":"22678952","id":"PMC_22678952","title":"Recurrent mutations in the CDKL5 gene: genotype-phenotype relationships.","date":"2012","source":"American journal of medical genetics. Part A","url":"https://pubmed.ncbi.nlm.nih.gov/22678952","citation_count":50,"is_preprint":false},{"pmid":"29977282","id":"PMC_29977282","title":"Heterozygous CDKL5 Knockout Female Mice Are a Valuable Animal Model for CDKL5 Disorder.","date":"2018","source":"Neural plasticity","url":"https://pubmed.ncbi.nlm.nih.gov/29977282","citation_count":50,"is_preprint":false},{"pmid":"25315662","id":"PMC_25315662","title":"Neurodevelopmental and neurobehavioral characteristics in males and females with CDKL5 duplications.","date":"2014","source":"European journal of human genetics : EJHG","url":"https://pubmed.ncbi.nlm.nih.gov/25315662","citation_count":41,"is_preprint":false},{"pmid":"26849555","id":"PMC_26849555","title":"CDKL5 and Shootin1 Interact and Concur in Regulating Neuronal Polarization.","date":"2016","source":"PloS one","url":"https://pubmed.ncbi.nlm.nih.gov/26849555","citation_count":41,"is_preprint":false},{"pmid":"22921766","id":"PMC_22921766","title":"CDKL5, a novel MYCN-repressed gene, blocks cell cycle and promotes differentiation of neuronal cells.","date":"2012","source":"Biochimica et biophysica acta","url":"https://pubmed.ncbi.nlm.nih.gov/22921766","citation_count":40,"is_preprint":false},{"pmid":"20493745","id":"PMC_20493745","title":"Epilepsy caused by CDKL5 mutations.","date":"2010","source":"European journal of paediatric neurology : EJPN : official journal of the European Paediatric Neurology Society","url":"https://pubmed.ncbi.nlm.nih.gov/20493745","citation_count":40,"is_preprint":false},{"pmid":"35997111","id":"PMC_35997111","title":"CDKL5 deficiency disorder: molecular insights and mechanisms of pathogenicity to fast-track therapeutic development.","date":"2022","source":"Biochemical Society transactions","url":"https://pubmed.ncbi.nlm.nih.gov/35997111","citation_count":38,"is_preprint":false},{"pmid":"17049193","id":"PMC_17049193","title":"Seizures and electroencephalographic findings in CDKL5 mutations: case report and review.","date":"2006","source":"Brain & development","url":"https://pubmed.ncbi.nlm.nih.gov/17049193","citation_count":38,"is_preprint":false},{"pmid":"31618813","id":"PMC_31618813","title":"Rett Syndrome and CDKL5 Deficiency Disorder: From Bench to Clinic.","date":"2019","source":"International journal of molecular sciences","url":"https://pubmed.ncbi.nlm.nih.gov/31618813","citation_count":37,"is_preprint":false},{"pmid":"17089071","id":"PMC_17089071","title":"MECP2 and CDKL5 gene mutation analysis in Chinese patients with Rett syndrome.","date":"2006","source":"Journal of human genetics","url":"https://pubmed.ncbi.nlm.nih.gov/17089071","citation_count":37,"is_preprint":false},{"pmid":"24564546","id":"PMC_24564546","title":"Clinical features and gene mutational spectrum of CDKL5-related diseases in a cohort of Chinese patients.","date":"2014","source":"BMC medical genetics","url":"https://pubmed.ncbi.nlm.nih.gov/24564546","citation_count":37,"is_preprint":false},{"pmid":"31925439","id":"PMC_31925439","title":"Artificial escape from XCI by DNA methylation editing of the CDKL5 gene.","date":"2020","source":"Nucleic acids research","url":"https://pubmed.ncbi.nlm.nih.gov/31925439","citation_count":36,"is_preprint":false},{"pmid":"33400301","id":"PMC_33400301","title":"CDKL5 deficiency in forebrain glutamatergic neurons results in recurrent spontaneous seizures.","date":"2021","source":"Epilepsia","url":"https://pubmed.ncbi.nlm.nih.gov/33400301","citation_count":36,"is_preprint":false},{"pmid":"28230307","id":"PMC_28230307","title":"CDKL5 deficiency entails sleep apneas in mice.","date":"2017","source":"Journal of sleep research","url":"https://pubmed.ncbi.nlm.nih.gov/28230307","citation_count":35,"is_preprint":false},{"pmid":"27108663","id":"PMC_27108663","title":"CDKL5 knockout leads to altered inhibitory transmission in the cerebellum of adult mice.","date":"2016","source":"Genes, brain, and behavior","url":"https://pubmed.ncbi.nlm.nih.gov/27108663","citation_count":35,"is_preprint":false},{"pmid":"16326141","id":"PMC_16326141","title":"Myoclonic encephalopathy in the CDKL5 gene mutation.","date":"2005","source":"Clinical neurophysiology : official journal of the International Federation of Clinical Neurophysiology","url":"https://pubmed.ncbi.nlm.nih.gov/16326141","citation_count":33,"is_preprint":false},{"pmid":"35633486","id":"PMC_35633486","title":"CDKL5 Deficiency Disorder-Related Epilepsy: A Review of Current and Emerging Treatment.","date":"2022","source":"CNS drugs","url":"https://pubmed.ncbi.nlm.nih.gov/35633486","citation_count":31,"is_preprint":false},{"pmid":"34605059","id":"PMC_34605059","title":"CDKL5 kinase controls transcription-coupled responses to DNA damage.","date":"2021","source":"The EMBO journal","url":"https://pubmed.ncbi.nlm.nih.gov/34605059","citation_count":30,"is_preprint":false},{"pmid":"32587608","id":"PMC_32587608","title":"Cyclin-Dependent Kinase-Like 5 (CDKL5): Possible Cellular Signalling Targets and Involvement in CDKL5 Deficiency Disorder.","date":"2020","source":"Neural plasticity","url":"https://pubmed.ncbi.nlm.nih.gov/32587608","citation_count":30,"is_preprint":false},{"pmid":"33047306","id":"PMC_33047306","title":"Exploring genotype-phenotype relationships in the CDKL5 deficiency disorder using an international dataset.","date":"2020","source":"Clinical genetics","url":"https://pubmed.ncbi.nlm.nih.gov/33047306","citation_count":30,"is_preprint":false},{"pmid":"30326240","id":"PMC_30326240","title":"Rescue of prepulse inhibition deficit and brain mitochondrial dysfunction by pharmacological stimulation of the central serotonin receptor 7 in a mouse model of CDKL5 Deficiency Disorder.","date":"2018","source":"Neuropharmacology","url":"https://pubmed.ncbi.nlm.nih.gov/30326240","citation_count":30,"is_preprint":false},{"pmid":"28740074","id":"PMC_28740074","title":"CDKL5 localizes at the centrosome and midbody and is required for faithful cell division.","date":"2017","source":"Scientific reports","url":"https://pubmed.ncbi.nlm.nih.gov/28740074","citation_count":29,"is_preprint":false},{"pmid":"21832092","id":"PMC_21832092","title":"Extrasynaptic N-methyl-D-aspartate (NMDA) receptor stimulation induces cytoplasmic translocation of the CDKL5 kinase and its proteasomal degradation.","date":"2011","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/21832092","citation_count":29,"is_preprint":false},{"pmid":"30793413","id":"PMC_30793413","title":"CDKL5 deficiency predisposes neurons to cell death through the deregulation of SMAD3 signaling.","date":"2019","source":"Brain pathology (Zurich, Switzerland)","url":"https://pubmed.ncbi.nlm.nih.gov/30793413","citation_count":28,"is_preprint":false},{"pmid":"33989939","id":"PMC_33989939","title":"CDKL5 deficiency disorder in males: Five new variants and review of the literature.","date":"2021","source":"European journal of paediatric neurology : EJPN : official journal of the European Paediatric Neurology Society","url":"https://pubmed.ncbi.nlm.nih.gov/33989939","citation_count":28,"is_preprint":false},{"pmid":"29618004","id":"PMC_29618004","title":"The antidepressant tianeptine reverts synaptic AMPA receptor defects caused by deficiency of CDKL5.","date":"2018","source":"Human molecular genetics","url":"https://pubmed.ncbi.nlm.nih.gov/29618004","citation_count":28,"is_preprint":false},{"pmid":"33538404","id":"PMC_33538404","title":"Ataluren for drug-resistant epilepsy in nonsense variant-mediated Dravet syndrome and CDKL5 deficiency disorder.","date":"2021","source":"Annals of clinical and translational neurology","url":"https://pubmed.ncbi.nlm.nih.gov/33538404","citation_count":28,"is_preprint":false},{"pmid":"20397747","id":"PMC_20397747","title":"Cyclin-dependent kinase-like 5 (CDKL5) mutation screening in Rett syndrome and related disorders.","date":"2010","source":"Twin research and human genetics : the official journal of the International Society for Twin Studies","url":"https://pubmed.ncbi.nlm.nih.gov/20397747","citation_count":27,"is_preprint":false},{"pmid":"31122804","id":"PMC_31122804","title":"Phenotypic manifestations between male and female children with CDKL5 mutations.","date":"2019","source":"Brain & development","url":"https://pubmed.ncbi.nlm.nih.gov/31122804","citation_count":27,"is_preprint":false},{"pmid":"34544833","id":"PMC_34544833","title":"CDKL5 Deficiency Augments Inhibitory Input into the Dentate Gyrus That Can Be Reversed by Deep Brain Stimulation.","date":"2021","source":"The Journal of neuroscience : the official journal of the Society for Neuroscience","url":"https://pubmed.ncbi.nlm.nih.gov/34544833","citation_count":27,"is_preprint":false},{"pmid":"22430159","id":"PMC_22430159","title":"Variant of Rett syndrome and CDKL5 gene: clinical and autonomic description of 10 cases.","date":"2012","source":"Neuropediatrics","url":"https://pubmed.ncbi.nlm.nih.gov/22430159","citation_count":26,"is_preprint":false},{"pmid":"34547934","id":"PMC_34547934","title":"Cerebral Visual Impairment in CDKL5 Deficiency Disorder Correlates With Developmental Achievement.","date":"2021","source":"Journal of child neurology","url":"https://pubmed.ncbi.nlm.nih.gov/34547934","citation_count":26,"is_preprint":false},{"pmid":"33436160","id":"PMC_33436160","title":"Clinical manifestations and epilepsy treatment in Japanese patients with pathogenic CDKL5 variants.","date":"2021","source":"Brain & development","url":"https://pubmed.ncbi.nlm.nih.gov/33436160","citation_count":24,"is_preprint":false},{"pmid":"32002787","id":"PMC_32002787","title":"Increased DNA Damage and Apoptosis in CDKL5-Deficient Neurons.","date":"2020","source":"Molecular neurobiology","url":"https://pubmed.ncbi.nlm.nih.gov/32002787","citation_count":23,"is_preprint":false},{"pmid":"31450582","id":"PMC_31450582","title":"Splicing Mutations Impairing CDKL5 Expression and Activity Can be Efficiently Rescued by U1snRNA-Based Therapy.","date":"2019","source":"International journal of molecular sciences","url":"https://pubmed.ncbi.nlm.nih.gov/31450582","citation_count":23,"is_preprint":false},{"pmid":"38081835","id":"PMC_38081835","title":"Epilepsy-linked kinase CDKL5 phosphorylates voltage-gated calcium channel Cav2.3, altering inactivation kinetics and neuronal excitability.","date":"2023","source":"Nature communications","url":"https://pubmed.ncbi.nlm.nih.gov/38081835","citation_count":22,"is_preprint":false},{"pmid":"31438497","id":"PMC_31438497","title":"Microtubules: A Key to Understand and Correct Neuronal Defects in CDKL5 Deficiency Disorder?","date":"2019","source":"International journal of molecular sciences","url":"https://pubmed.ncbi.nlm.nih.gov/31438497","citation_count":21,"is_preprint":false},{"pmid":"25266480","id":"PMC_25266480","title":"Optimizing the molecular diagnosis of CDKL5 gene-related epileptic encephalopathy in boys.","date":"2014","source":"Epilepsia","url":"https://pubmed.ncbi.nlm.nih.gov/25266480","citation_count":21,"is_preprint":false},{"pmid":"27840050","id":"PMC_27840050","title":"Subcellular distribution of cyclin-dependent kinase-like 5 (CDKL5) is regulated through phosphorylation by dual specificity tyrosine-phosphorylation-regulated kinase 1A (DYRK1A).","date":"2016","source":"Biochemical and biophysical research communications","url":"https://pubmed.ncbi.nlm.nih.gov/27840050","citation_count":21,"is_preprint":false},{"pmid":"33044867","id":"PMC_33044867","title":"Involvement of the CDKL5-SOX9 signaling axis in rhabdomyolysis-associated acute kidney injury.","date":"2020","source":"American journal of physiology. Renal physiology","url":"https://pubmed.ncbi.nlm.nih.gov/33044867","citation_count":20,"is_preprint":false},{"pmid":"31232219","id":"PMC_31232219","title":"Aminoglycoside drugs induce efficient read-through of CDKL5 nonsense mutations, slightly restoring its kinase activity.","date":"2019","source":"RNA biology","url":"https://pubmed.ncbi.nlm.nih.gov/31232219","citation_count":20,"is_preprint":false},{"pmid":"35445702","id":"PMC_35445702","title":"Touchscreen cognitive deficits, hyperexcitability and hyperactivity in males and females using two models of Cdkl5 deficiency.","date":"2022","source":"Human molecular genetics","url":"https://pubmed.ncbi.nlm.nih.gov/35445702","citation_count":19,"is_preprint":false},{"pmid":"37011526","id":"PMC_37011526","title":"Efficacy, safety, and tolerability of soticlestat as adjunctive therapy for the treatment of seizures in patients with Dup15q syndrome or CDKL5 deficiency disorder in an open-label signal-finding phase II study (ARCADE).","date":"2023","source":"Epilepsy & behavior : E&B","url":"https://pubmed.ncbi.nlm.nih.gov/37011526","citation_count":19,"is_preprint":false},{"pmid":"38326557","id":"PMC_38326557","title":"Cell type-specific expression, regulation and compensation of CDKL5 activity in mouse brain.","date":"2024","source":"Molecular psychiatry","url":"https://pubmed.ncbi.nlm.nih.gov/38326557","citation_count":18,"is_preprint":false},{"pmid":"36759195","id":"PMC_36759195","title":"Epilepsy-Related CDKL5 Deficiency Slows Synaptic Vesicle Endocytosis in Central Nerve Terminals.","date":"2023","source":"The Journal of neuroscience : the official journal of the Society for Neuroscience","url":"https://pubmed.ncbi.nlm.nih.gov/36759195","citation_count":18,"is_preprint":false},{"pmid":"36202289","id":"PMC_36202289","title":"Neuronal hyperexcitability and ion channel dysfunction in CDKL5-deficiency patient iPSC-derived cortical organoids.","date":"2022","source":"Neurobiology of disease","url":"https://pubmed.ncbi.nlm.nih.gov/36202289","citation_count":18,"is_preprint":false},{"pmid":"25905439","id":"PMC_25905439","title":"Critical Determinants of Substrate Recognition by Cyclin-Dependent Kinase-like 5 (CDKL5).","date":"2015","source":"Biochemistry","url":"https://pubmed.ncbi.nlm.nih.gov/25905439","citation_count":18,"is_preprint":false},{"pmid":"30288694","id":"PMC_30288694","title":"Neuron-Type Specific Loss of CDKL5 Leads to Alterations in mTOR Signaling and Synaptic Markers.","date":"2018","source":"Molecular neurobiology","url":"https://pubmed.ncbi.nlm.nih.gov/30288694","citation_count":18,"is_preprint":false},{"pmid":"36109452","id":"PMC_36109452","title":"Expression of a Secretable, Cell-Penetrating CDKL5 Protein Enhances the Efficacy of Gene Therapy for CDKL5 Deficiency Disorder.","date":"2022","source":"Neurotherapeutics : the journal of the American Society for Experimental NeuroTherapeutics","url":"https://pubmed.ncbi.nlm.nih.gov/36109452","citation_count":17,"is_preprint":false},{"pmid":"35153983","id":"PMC_35153983","title":"Cortical Visual Impairment in CDKL5 Deficiency Disorder.","date":"2022","source":"Frontiers in neurology","url":"https://pubmed.ncbi.nlm.nih.gov/35153983","citation_count":17,"is_preprint":false},{"pmid":"37429835","id":"PMC_37429835","title":"CDKL5 deficiency disorder: progressive brain atrophy may be part of the syndrome.","date":"2023","source":"Cerebral cortex (New York, N.Y. : 1991)","url":"https://pubmed.ncbi.nlm.nih.gov/37429835","citation_count":17,"is_preprint":false},{"pmid":"34073043","id":"PMC_34073043","title":"Treatment with a GSK-3β/HDAC Dual Inhibitor Restores Neuronal Survival and Maturation in an In Vitro and In Vivo Model of CDKL5 Deficiency Disorder.","date":"2021","source":"International journal of molecular sciences","url":"https://pubmed.ncbi.nlm.nih.gov/34073043","citation_count":17,"is_preprint":false},{"pmid":"37917202","id":"PMC_37917202","title":"CDKL5 regulates p62-mediated selective autophagy and confers protection against neurotropic viruses.","date":"2024","source":"The Journal of clinical investigation","url":"https://pubmed.ncbi.nlm.nih.gov/37917202","citation_count":16,"is_preprint":false},{"pmid":"28580010","id":"PMC_28580010","title":"Molecular and genetic insights into an infantile epileptic encephalopathy - CDKL5 disorder.","date":"2017","source":"Frontiers in biology","url":"https://pubmed.ncbi.nlm.nih.gov/28580010","citation_count":16,"is_preprint":false},{"pmid":"33905871","id":"PMC_33905871","title":"Abnormalities of mitochondrial dynamics and bioenergetics in neuronal cells from CDKL5 deficiency disorder.","date":"2021","source":"Neurobiology of disease","url":"https://pubmed.ncbi.nlm.nih.gov/33905871","citation_count":15,"is_preprint":false},{"pmid":"23756444","id":"PMC_23756444","title":"Mutations in the C-terminus of CDKL5: proceed with caution.","date":"2013","source":"European journal of human genetics : EJHG","url":"https://pubmed.ncbi.nlm.nih.gov/23756444","citation_count":15,"is_preprint":false},{"pmid":"27900411","id":"PMC_27900411","title":"Inflammatory protein response in CDKL5-Rett syndrome: evidence of a subclinical smouldering inflammation.","date":"2016","source":"Inflammation research : official journal of the European Histamine Research Society ... [et al.]","url":"https://pubmed.ncbi.nlm.nih.gov/27900411","citation_count":15,"is_preprint":false},{"pmid":"33621640","id":"PMC_33621640","title":"A GABAB receptor antagonist rescues functional and structural impairments in the perirhinal cortex of a mouse model of CDKL5 deficiency disorder.","date":"2021","source":"Neurobiology of disease","url":"https://pubmed.ncbi.nlm.nih.gov/33621640","citation_count":15,"is_preprint":false},{"pmid":"35665761","id":"PMC_35665761","title":"Cdkl5 mutant zebrafish shows skeletal and neuronal alterations mimicking human CDKL5 deficiency disorder.","date":"2022","source":"Scientific reports","url":"https://pubmed.ncbi.nlm.nih.gov/35665761","citation_count":14,"is_preprint":false}],"cost":{"stage1":{"model":"claude-sonnet-4-6","input_tokens":51163,"output_tokens":8303,"usd":0.139017,"stage1_stop_reason":"end_turn"},"stage2":{"model":"claude-opus-4-8","input_tokens":17980,"output_tokens":5231,"usd":0.110338,"stage2_stop_reason":"end_turn"},"total_usd":0.249355,"stage1_batch_id":"msgbatch_01ACAxJQabDsht39JXeWG22d","stage2_batch_id":"msgbatch_01QEU22A9U5sbPTgsMzTmvSf","note":"batch pricing = 50% of standard"},"stage1_raw":"```json\n{\n  \"discoveries\": [\n    {\n      \"year\": 2005,\n      \"finding\": \"CDKL5 physically interacts with MeCP2 both in vivo and in vitro, and CDKL5 kinase activity mediates phosphorylation of MeCP2 as well as autophosphorylation, placing the two proteins in a common molecular pathway.\",\n      \"method\": \"Co-immunoprecipitation (in vivo), in vitro kinase assay, immunostaining\",\n      \"journal\": \"Human molecular genetics\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1–2 / Moderate — in vitro kinase assay plus reciprocal Co-IP, replicated in same study across multiple experimental systems\",\n      \"pmids\": [\"15917271\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2005,\n      \"finding\": \"CDKL5 is a nuclear protein expressed in neurons during neural maturation and synaptogenesis, and its subcellular localization overlaps with MeCP2 in the nervous system.\",\n      \"method\": \"Immunostaining, Western blotting, fractionation\",\n      \"journal\": \"Human molecular genetics\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — direct localization by immunostaining in brain tissue with developmental staging\",\n      \"pmids\": [\"15917271\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2005,\n      \"finding\": \"Disease-causing missense mutations in the CDKL5 kinase domain, affecting highly conserved amino acids, impair catalytic activity as assessed by autophosphorylation, indicating that kinase inactivation underlies pathogenesis.\",\n      \"method\": \"In vitro autophosphorylation kinase assay with patient-derived mutant forms of CDKL5\",\n      \"journal\": \"American journal of human genetics\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 1 / Weak — in vitro kinase assay on patient-derived mutants, single study\",\n      \"pmids\": [\"15499549\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2005,\n      \"finding\": \"CDKL5 is primarily localized in the nucleus; removal of the C-terminal domain increases expression, enhances autophosphorylation activity, and causes perinuclear (cytoplasmic) localization, demonstrating that the C-terminus negatively regulates kinase activity and controls nuclear localization.\",\n      \"method\": \"Transfection of C-terminal deletion constructs, subcellular fractionation, in vitro kinase assay\",\n      \"journal\": \"Human molecular genetics\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 1–2 / Weak — in vitro kinase assay plus localization by fractionation, single lab\",\n      \"pmids\": [\"16330482\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2005,\n      \"finding\": \"CDKL5 detected binding to MeCP2 but not to ARX; neither MeCP2 nor ARX was confirmed as a direct phosphorylation substrate by CDKL5 in this study (negative finding for direct MeCP2 phosphorylation).\",\n      \"method\": \"Co-immunoprecipitation, in vitro kinase assay\",\n      \"journal\": \"Human molecular genetics\",\n      \"confidence\": \"Low\",\n      \"confidence_rationale\": \"Tier 2 / Weak — single lab, single Co-IP, contradicts paper 15917271; noted as negative finding\",\n      \"pmids\": [\"16330482\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2006,\n      \"finding\": \"Disease-causing CDKL5 mutations show both impaired and increased catalytic activity relative to wild-type; wild-type CDKL5 autophosphorylates its TEY motif and phosphorylates MeCP2 in vitro; CDKL5 can self-associate (homo-oligomerize); the C-terminus negatively regulates catalytic activity and is required for proper sub-nuclear localization.\",\n      \"method\": \"In vitro kinase assay, TEY phosphorylation analysis, co-immunoprecipitation for self-association, subcellular localization by immunofluorescence\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1–2 / Moderate — in vitro kinase assay plus mutagenesis plus Co-IP plus localization, multiple orthogonal methods in one study\",\n      \"pmids\": [\"16935860\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2008,\n      \"finding\": \"CDKL5 subcellular distribution is regulated by its C-terminal tail: the C-terminus is required for cytoplasmic localization via active nuclear export, while Rett-syndrome truncations of the C-terminus cause constitutive nuclear accumulation. CDKL5 shuttles between nucleus and cytoplasm during neuronal development.\",\n      \"method\": \"Immunostaining of brain sections, subcellular fractionation, C-terminal deletion/truncation constructs, nuclear export inhibition\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — direct localization experiments combined with deletion constructs and nuclear export inhibition, multiple orthogonal methods\",\n      \"pmids\": [\"18701457\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2009,\n      \"finding\": \"CDKL5 localizes to nuclear speckles (pre-mRNA splicing factor storage/modification sites), regulates their morphology in a kinase-activity-dependent manner, and influences alternative splicing activity.\",\n      \"method\": \"Immunofluorescence co-localization with speckle markers, CDKL5 overexpression/knockdown, minigene splicing assay\",\n      \"journal\": \"Human molecular genetics\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — direct localization by immunofluorescence plus functional minigene assay plus knockdown, single lab\",\n      \"pmids\": [\"19740913\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2010,\n      \"finding\": \"Cdkl5 is a MeCP2-repressed target gene: increased MeCP2 levels repress Cdkl5 expression, Cdkl5 promoter methylation increases upon MeCP2 upregulation, and MeCP2 binds the methylated Cdkl5 promoter; siRNA knockdown of MeCP2 or inhibition of DNA methyltransferases induces Cdkl5 expression.\",\n      \"method\": \"MeCP2 overexpression/siRNA knockdown, DNA methylation analysis, chromatin immunoprecipitation (ChIP), quantitative PCR\",\n      \"journal\": \"Neurobiology of disease\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — ChIP plus methylation analysis plus functional rescue experiments, single lab\",\n      \"pmids\": [\"20211261\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2010,\n      \"finding\": \"CDKL5 regulates neuronal morphogenesis via Rac1 signaling: CDKL5 colocalizes and forms a protein complex with Rac1 in neurons and fibroblasts; CDKL5 knockdown inhibits neurite growth and dendritic arborization; overexpression of Rac1 rescues dendritic defects from CDKL5 knockdown; dominant-negative Rac1 abolishes the growth-promoting effect of CDKL5; CDKL5 is required for BDNF-induced Rac1 activation.\",\n      \"method\": \"RNAi knockdown, overexpression, in utero electroporation, Co-immunoprecipitation, Rac1 activation assay, BDNF stimulation\",\n      \"journal\": \"The Journal of neuroscience\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — reciprocal Co-IP, epistasis rescue experiments, in vivo knockdown, and BDNF-Rac1 activation assay across multiple methods and cellular contexts\",\n      \"pmids\": [\"20861382\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2011,\n      \"finding\": \"Extrasynaptic NMDA receptor activation induces nuclear-to-cytoplasmic translocation of endogenous CDKL5 in hippocampal neurons followed by proteasomal degradation; CDKL5 does not constitutively shuttle between nucleus and cytoplasm in post-mitotic neurons unlike in proliferating cells.\",\n      \"method\": \"Immunofluorescence in primary hippocampal neurons, glutamate/NMDA stimulation, proteasome inhibitor treatment, subcellular fractionation\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — direct localization imaging plus pharmacological dissection, single lab, multiple conditions\",\n      \"pmids\": [\"21832092\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2012,\n      \"finding\": \"CDKL5 loss-of-function in mice disrupts multiple signal transduction pathways including the AKT-mTOR cascade, as revealed by kinome profiling, and leads to autistic-like behavioral deficits.\",\n      \"method\": \"Cdkl5 knockout mouse, kinome profiling, behavioral analysis\",\n      \"journal\": \"Proceedings of the National Academy of Sciences of the United States of America\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — kinome profiling plus behavioral phenotyping in KO mouse, single lab\",\n      \"pmids\": [\"23236174\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2012,\n      \"finding\": \"CDKL5 overexpression in neuroblastoma cells causes G0/G1 cell cycle arrest and promotes differentiation; MYCN acts as a direct transcriptional repressor of the CDKL5 promoter, establishing a MYCN–CDKL5 axis governing neuronal proliferation and differentiation.\",\n      \"method\": \"Overexpression in neuroblastoma cells, flow cytometry, ChIP, promoter reporter assays, MYCN knockdown\",\n      \"journal\": \"Biochimica et biophysica acta\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — ChIP plus reporter assay plus flow cytometry, single lab, multiple methods\",\n      \"pmids\": [\"22921766\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2013,\n      \"finding\": \"CDKL5 binds directly to the scaffolding protein PSD-95 in a palmitoylation-dependent manner, and this interaction is required for synaptic targeting of CDKL5; pathogenic C-terminal truncation mutations reduce CDKL5–PSD-95 binding and synaptic accumulation; loss of CDKL5 or disruption of CDKL5–PSD-95 interaction inhibits dendritic spine formation and growth.\",\n      \"method\": \"Co-immunoprecipitation, palmitoylation manipulation, RNAi knockdown, overexpression, immunofluorescence\",\n      \"journal\": \"Proceedings of the National Academy of Sciences of the United States of America\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — reciprocal Co-IP, palmitoylation manipulation, pathogenic mutant analysis, and RNAi spine phenotype, multiple orthogonal methods\",\n      \"pmids\": [\"23671101\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2014,\n      \"finding\": \"CDKL5 loss impairs AKT/GSK-3β signaling, reduces survival of newborn neurons, decreases total granule cell number in hippocampal dentate gyrus, and causes dendritic hypotrophy of newly generated granule cells.\",\n      \"method\": \"Cdkl5 knockout mouse, Western blotting for AKT/GSK-3β pathway, immunohistochemistry, BrdU labeling, behavioral testing\",\n      \"journal\": \"Neurobiology of disease\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — KO mouse with defined cellular phenotype and pathway analysis, single lab\",\n      \"pmids\": [\"24952363\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2014,\n      \"finding\": \"Loss of CDKL5 in cortical neurons reduces dendritic arborization; conditional knockout in excitatory versus inhibitory forebrain neurons maps behavioral phenotypes to separable cell types; Akt/rpS6 signaling is altered in CDKL5-deficient neurons.\",\n      \"method\": \"Conditional Cre-loxP knockout mice (excitatory and inhibitory neuron-specific), morphological analysis, EEG, behavioral testing, Western blotting\",\n      \"journal\": \"PloS one\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — cell-type-specific conditional KO with defined phenotypic readouts, single lab\",\n      \"pmids\": [\"24838000\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2015,\n      \"finding\": \"CDKL5 phosphorylates amphiphysin 1 (Amph1) at Ser-293, and substrate recognition requires an arginine at the P-3 position and a proline at P-2 (consensus RPXSX); the Amph2 CLAP domain contributes to efficient phosphorylation.\",\n      \"method\": \"In vitro kinase assay with Amph1/Amph2 mutants, site-directed mutagenesis, phosphorylation mapping\",\n      \"journal\": \"Biochemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Moderate — in vitro kinase assay with systematic mutagenesis of substrate recognition motif, rigorous biochemical characterization\",\n      \"pmids\": [\"25905439\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2016,\n      \"finding\": \"CDKL5 interacts with and is phosphorylated at Ser-308 by DYRK1A; DYRK1A-mediated phosphorylation of CDKL5 at Ser-308 increases its cytoplasmic localization; phosphomimetic S308D mutation shifts CDKL5 to the cytosol while S308A keeps it nuclear.\",\n      \"method\": \"Co-immunoprecipitation, in vitro kinase assay, site-directed mutagenesis, immunofluorescence\",\n      \"journal\": \"Biochemical and biophysical research communications\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 1–2 / Moderate — in vitro kinase assay plus mutagenesis plus Co-IP, single lab\",\n      \"pmids\": [\"27840050\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2016,\n      \"finding\": \"CDKL5 interacts with shootin1 (a determinant of axon formation) in vivo; both proteins colocalize at the distal tip of outgrowing axons; CDKL5 loss disrupts neuronal polarization; CDKL5 overexpression generates supernumerary axons in a shootin1-dependent manner; shootin1 phosphorylation is reduced in CDKL5-silenced neurons.\",\n      \"method\": \"Yeast two-hybrid screening, Co-immunoprecipitation, immunofluorescence, RNAi knockdown, overexpression in hippocampal neurons\",\n      \"journal\": \"PloS one\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — reciprocal Co-IP plus in vivo neuronal localization plus RNAi epistasis, single lab\",\n      \"pmids\": [\"26849555\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2017,\n      \"finding\": \"CDKL5 deficiency in the hippocampus causes postsynaptic overaccumulation of GluN2B and SAP102, increased NMDA/AMPA ratio and prolonged NMDA-EPSC decay time; ifenprodil (GluN2B-selective antagonist) abrogates NMDA-induced hyperexcitability, indicating CDKL5 controls postsynaptic localization of the GluN2B–SAP102 complex.\",\n      \"method\": \"Cdkl5 knockout mouse, subcellular fractionation of PSD, immunoelectron microscopy, whole-cell patch clamp, pharmacological rescue\",\n      \"journal\": \"Neurobiology of disease\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1–2 / Strong — subcellular fractionation, immunoEM, electrophysiology, and pharmacological rescue using multiple orthogonal methods\",\n      \"pmids\": [\"28688852\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2017,\n      \"finding\": \"CDKL5 localizes to the centrosome and midbody in proliferating cells; its depletion by RNAi causes multipolar spindle formation and cytokinesis failure; CDKL5-depleted midbodies lack HIPK2 and H2B-S14 phosphorylation; expression of phosphomimetic H2B-S14D rescues spindle multipolarity.\",\n      \"method\": \"Immunofluorescence, RNAi knockdown, rescue with H2B-S14D phosphomimetic, microscopy of mitotic cells\",\n      \"journal\": \"Scientific reports\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — direct localization plus RNAi phenotype plus functional rescue, single lab\",\n      \"pmids\": [\"28740074\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2018,\n      \"finding\": \"Using chemical genetics (analog-sensitive kinase approach), CDKL5 was found to directly phosphorylate three microtubule-associated proteins — MAP1S, EB2, and ARHGEF2 — at defined sites; phosphorylation of these substrates is reduced in CDKL5 knockout mice (confirming physiological relevance); CDKL5 phosphorylation of MAP1S promotes its dissociation from microtubules; loss of CDKL5 leads to longer EB3-labelled dendritic microtubule plus-end growth, rescued by MAP1S shRNA; anterograde cargo trafficking is impaired in CDKL5 KO dendrites.\",\n      \"method\": \"Chemical genetics (analog-sensitive kinase), mass spectrometry, phospho-specific antibodies, CDKL5 KO mice, live imaging of EB3, shRNA knockdown, cargo trafficking assay\",\n      \"journal\": \"The EMBO journal\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Strong — chemical genetic substrate identification plus in vivo validation in KO mice plus mechanistic rescue experiments, multiple orthogonal methods\",\n      \"pmids\": [\"30266824\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2018,\n      \"finding\": \"Quantitative phosphoproteomic screen identified MAP1S (pSer900), CEP131 (pSer35), and DLG5 as cellular substrates of CDKL5; the phospho-acceptor motif is RPXSA; pathogenic CDKL5 mutations cause major reduction of kinase activity in vitro and in cells.\",\n      \"method\": \"Quantitative phosphoproteomics (SILAC), phospho-specific antibodies, in vitro kinase assay with patient-derived mutants\",\n      \"journal\": \"The EMBO journal\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Strong — SILAC-based proteomics plus phospho-antibody validation plus in vitro kinase assay, multiple orthogonal methods, independent replication of MAP1S as substrate\",\n      \"pmids\": [\"30266925\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2018,\n      \"finding\": \"Cdkl5 deficiency in primary hippocampal neurons causes reduced GluA2 subunit expression, hyper-phosphorylation of GluA2-Ser880, increased GluA2 ubiquitination, and a shift to GluA2-lacking calcium-permeable AMPARs at the synapse.\",\n      \"method\": \"RNAi knockdown in neurons, Western blotting, immunoprecipitation, surface AMPAR immunofluorescence\",\n      \"journal\": \"Human molecular genetics\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — biochemical characterization with multiple endpoints, single lab\",\n      \"pmids\": [\"29618004\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2019,\n      \"finding\": \"SMAD3 is a direct phosphorylation target of CDKL5; CDKL5-dependent phosphorylation stabilizes SMAD3 protein; CDKL5-deficient neurons show reduced SMAD3 signaling and are more vulnerable to excitotoxic stimuli; TGF-β1 treatment normalizes defective neuronal survival in Cdkl5 KO neurons and prevents NMDA-induced cell death in vivo.\",\n      \"method\": \"In vitro kinase assay, Western blotting in KO neurons, TGF-β1 rescue experiments in vitro and in vivo\",\n      \"journal\": \"Brain pathology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 1–2 / Moderate — in vitro kinase assay plus KO neuronal phenotype plus in vivo rescue, single lab\",\n      \"pmids\": [\"30793413\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2019,\n      \"finding\": \"Selective loss of CDKL5 in GABAergic neurons leads to autistic-like phenotypes in mice with excessive glutamatergic transmission, hyperexcitability, and increased postsynaptic NMDA receptors; acute low-dose NMDA receptor inhibition ameliorates autistic-like behaviors in GABAergic-specific and R59X knockin CDKL5 mice.\",\n      \"method\": \"Conditional GABAergic-specific Cre-lox KO, behavioral testing, electrophysiology, pharmacological rescue with NMDAR antagonist, knockin mouse model\",\n      \"journal\": \"Nature communications\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — cell-type specific KO plus electrophysiology plus pharmacological rescue, replicated in second model (R59X knockin)\",\n      \"pmids\": [\"31201320\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2020,\n      \"finding\": \"CDKL5 is a stress-responsive kinase in renal tubular epithelial cells that promotes cell death through phosphorylation-dependent suppression of the pro-survival transcription factor SOX9; genetic or pharmacological Cdkl5 inhibition protects against nephrotoxic and ischemia-associated acute kidney injury in mouse models.\",\n      \"method\": \"Kinome-wide RNAi screen, conditional Cdkl5 gene ablation in RTECs, kinase assay with SOX9, pharmacological inhibition (AST-487), mouse AKI models\",\n      \"journal\": \"Nature communications\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1–2 / Strong — in vitro kinase assay for SOX9 phosphorylation, cell-type-specific KO, pharmacological inhibition, replicated across two AKI models\",\n      \"pmids\": [\"32317630\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2021,\n      \"finding\": \"CDKL5 is recruited to sites of DNA damage in actively transcribed regions; a nuclear phosphoproteomic screen identified Elongin A (ELOA) as a CDKL5 substrate phosphorylated on a CDKL5 consensus motif; CDKL5 recruitment and ELOA phosphorylation require active transcription and poly(ADP-ribose) (PAR) synthesis, to which CDKL5 can bind; CDKL5 kinase activity is essential for transcriptional silencing at sites of DNA double-strand breaks.\",\n      \"method\": \"Quantitative nuclear phosphoproteomics, PAR binding assay, recruitment to DNA damage sites by imaging, transcription inhibition experiments, kinase-dead mutant analysis\",\n      \"journal\": \"The EMBO journal\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1–2 / Strong — nuclear phosphoproteomics plus PAR binding plus localization imaging plus kinase-dead functional analysis, multiple orthogonal methods\",\n      \"pmids\": [\"34605059\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2021,\n      \"finding\": \"Postdevelopmental (adult-stage) loss of CDKL5 disrupts behavioral domains, hippocampal circuit communication, and dendritic spine morphology; restoration of Cdkl5 expression after early brain development ameliorates CDD-related behavioral impairments and aberrant NMDA receptor signaling, demonstrating that CDKL5 function is required beyond early development.\",\n      \"method\": \"Temporal conditional knockout and rescue mouse models (inducible Cre), behavioral testing, electrophysiology, dendritic spine morphology analysis\",\n      \"journal\": \"The Journal of clinical investigation\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — temporal KO and conditional rescue experiments with behavioral and electrophysiological phenotyping, orthogonal methods\",\n      \"pmids\": [\"34651584\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2021,\n      \"finding\": \"CDKL5 deficiency in glutamatergic (Emx1- or CamK2α-Cre) but not GABAergic neurons generates high-frequency spontaneous recurrent seizures, accompanied by hippocampal mossy fiber sprouting and increased excitatory synaptic activity (higher frequency but unchanged amplitude of sEPSCs and mEPSCs in dentate granule cells).\",\n      \"method\": \"Cell-type-specific conditional KO (Emx1-Cre, CamK2α-Cre, GAD-Cre), in vivo EEG/video, Timm staining for mossy fiber sprouting, whole-cell patch clamp\",\n      \"journal\": \"Epilepsia\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — multiple cell-type-specific KO lines, in vivo electrophysiology, morphological analysis, and patch clamp, multiple orthogonal methods\",\n      \"pmids\": [\"33400301\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2023,\n      \"finding\": \"CDKL5 directly phosphorylates the voltage-gated calcium channel Cav2.3 (CACNA1E); loss of Cav2.3 phosphorylation leads to channel gain-of-function via slower inactivation and enhanced cholinergic stimulation, increasing neuronal excitability; CDD is therefore partly a channelopathy sharing mechanistic features with CACNA1E gain-of-function DEE69.\",\n      \"method\": \"SILAC phosphoproteomic screen, recombinant channel electrophysiology, Cav2.3 phosphomutant knockin mice, CDKL5 KO mice, neuronal excitability recordings\",\n      \"journal\": \"Nature communications\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Strong — phosphoproteomic identification plus recombinant electrophysiology plus in vivo phosphomutant mouse, multiple orthogonal methods\",\n      \"pmids\": [\"38081835\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2023,\n      \"finding\": \"CDKL5 is selectively required for efficient synaptic vesicle (SV) endocytosis in hippocampal neurons; the isolated CDKL5 kinase domain fully restores SV endocytosis kinetics in KO neurons; kinase-inactive CDKL5 mutations fail to rescue endocytosis; phosphorylation of amphiphysin 1 by CDKL5 is not required for SV endocytosis (negative finding for Amph1 as presynaptic effector of endocytosis).\",\n      \"method\": \"Cdkl5 knockout rat hippocampal neurons, genetically encoded SV reporter, kinase-dead and domain-deletion constructs, rescue experiments\",\n      \"journal\": \"The Journal of neuroscience\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1–2 / Moderate — functional reporter assay plus kinase-dead mutagenesis plus domain rescue experiments, multiple orthogonal approaches\",\n      \"pmids\": [\"36759195\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2024,\n      \"finding\": \"CDKL5 and EB2 phosphorylation (pS222) are prominent in excitatory and inhibitory neurons but absent in astrocytes; ~15–20% residual EB2 pS222 persists in neuronal CDKL5 KO, regulated by NMDA and PP1/PP2A; CDKL2 and ICK can phosphorylate EB2-S222 in vitro; dual Cdkl5/Cdkl2 KO mice confirm that CDKL2 compensates CDKL5 substrate phosphorylation in vivo.\",\n      \"method\": \"Cell-type-specific conditional KO mice, phospho-specific antibody for EB2 pS222, kinase screen in HEK293T cells, dual KO mice\",\n      \"journal\": \"Molecular psychiatry\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — conditional KO with validated phospho-antibody plus in vitro kinase screen plus dual KO validation, single lab\",\n      \"pmids\": [\"38326557\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2024,\n      \"finding\": \"CDKL5 directly binds the selective autophagy receptor p62 and phosphorylates p62 at T269/S272; CDKL5-mediated p62 phosphorylation promotes large p62 inclusion body formation that captures viral capsids, initiating virophagy; CDKL5 deficiency reduces clearance of Sindbis virus capsid aggregates and increases neuronal cell death after neurotropic virus infection.\",\n      \"method\": \"Co-immunoprecipitation, in vitro kinase assay with p62 mutants, Cdkl5 KO mice infected with neurotropic viruses, imaging of p62 inclusion bodies\",\n      \"journal\": \"The Journal of clinical investigation\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1–2 / Strong — in vitro kinase assay plus Co-IP plus in vivo KO mouse virophagy phenotype, multiple orthogonal methods\",\n      \"pmids\": [\"37917202\"],\n      \"is_preprint\": false\n    }\n  ],\n  \"current_model\": \"CDKL5 is a brain-enriched serine/threonine kinase whose catalytic activity — regulated by C-terminal domain-mediated autoinhibition and DYRK1A-dependent phosphorylation at Ser-308 — is required for multiple neuronal functions including dendritic arborization via Rac1 signaling, synaptic maturation via PSD-95-dependent targeting and GluN2B/AMPAR regulation, dendritic microtubule dynamics via phosphorylation of MAP1S/EB2/ARHGEF2, axonal specification via shootin1 interaction, synaptic vesicle endocytosis, transcription-coupled DNA damage responses via Elongin A phosphorylation, and regulation of neuronal excitability through Cav2.3 channel phosphorylation; it also phosphorylates MeCP2, SMAD3, CEP131, DLG5, and p62 (the last regulating virophagy), and is itself transcriptionally repressed by MeCP2 binding to its methylated promoter and by MYCN.\"\n}\n```","stage2_raw":"{\n  \"mechanistic_narrative\": \"CDKL5 is a brain-enriched serine/threonine kinase that governs neuronal maturation, synaptic function, and excitability through phosphorylation of an expanding set of cytoskeletal, synaptic, and nuclear substrates [#9, #21, #30]. Its catalytic activity is intrinsically autoinhibited by its C-terminal domain, which also controls nucleocytoplasmic distribution: C-terminal truncation enhances autophosphorylation and shifts the kinase between nucleus and cytoplasm, and DYRK1A-mediated phosphorylation at Ser-308 promotes cytoplasmic localization [#3, #6, #17]. CDKL5 recognizes substrates through an RPXS(A) consensus motif and phosphorylates the microtubule regulators MAP1S, EB2, and ARHGEF2 to control dendritic microtubule plus-end dynamics and cargo trafficking, the centrosomal protein CEP131, and DLG5 [#16, #21, #22]. In neurons it drives dendritic arborization and spine formation via a Rac1 complex and BDNF-dependent Rac1 activation, and via palmitoylation-dependent binding to PSD-95 that targets it to synapses [#9, #13]. CDKL5 controls excitatory signaling by restraining postsynaptic GluN2B–SAP102 NMDA receptors and GluA2-containing AMPARs, and by phosphorylating the Cav2.3 (CACNA1E) calcium channel, such that its loss produces a partial channelopathy and hyperexcitability [#19, #23, #30]. Beyond development, CDKL5 phosphorylates SMAD3 to support neuronal survival, mediates synaptic vesicle endocytosis through its kinase domain, is recruited via poly(ADP-ribose) to transcription-coupled DNA damage sites where it phosphorylates Elongin A to enable transcriptional silencing, and phosphorylates p62 to initiate virophagy [#24, #27, #31, #33]. CDKL5 also physically interacts with and is in a common pathway with MeCP2, which transcriptionally represses Cdkl5 by binding its methylated promoter, while MYCN represses CDKL5 in proliferating cells [#0, #8, #12]. Restoring CDKL5 after early development reverses behavioral and NMDA receptor signaling deficits, establishing an ongoing adult requirement [#28].\",\n  \"teleology\": [\n    {\n      \"year\": 2005,\n      \"claim\": \"Establishing CDKL5 as an active kinase physically and functionally linked to MeCP2 placed it within the Rett-spectrum disorder pathway and gave it a candidate substrate.\",\n      \"evidence\": \"Co-IP and in vitro kinase assays in brain and cell systems\",\n      \"pmids\": [\"15917271\", \"15499549\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"A later study failed to confirm direct MeCP2 phosphorylation\", \"Physiological consequences of MeCP2 phosphorylation not defined\"]\n    },\n    {\n      \"year\": 2006,\n      \"claim\": \"Identifying C-terminal autoinhibition, TEY-motif autophosphorylation, and self-association defined how CDKL5 catalytic output and localization are intrinsically regulated.\",\n      \"evidence\": \"In vitro kinase assays, mutagenesis, Co-IP, and fractionation/immunofluorescence\",\n      \"pmids\": [\"16330482\", \"16935860\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Structural basis of autoinhibition unresolved\", \"Trigger that relieves autoinhibition in vivo unknown\"]\n    },\n    {\n      \"year\": 2008,\n      \"claim\": \"Demonstrating C-terminus-dependent nuclear export and developmental shuttling explained how Rett truncations cause aberrant nuclear accumulation.\",\n      \"evidence\": \"Brain immunostaining, fractionation, truncation constructs, nuclear export inhibition\",\n      \"pmids\": [\"18701457\", \"19740913\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Export receptor/NES not mapped\", \"Functional role of nuclear speckle localization unclear\"]\n    },\n    {\n      \"year\": 2010,\n      \"claim\": \"Showing CDKL5 forms a Rac1 complex required for BDNF-induced Rac1 activation and dendritic growth gave the kinase its first concrete neuronal morphogenesis role.\",\n      \"evidence\": \"RNAi, in utero electroporation, Co-IP, Rac1 activation assay, epistasis rescue\",\n      \"pmids\": [\"20861382\", \"20211261\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Direct Rac1 GEF/effector phosphorylated by CDKL5 not identified here\", \"Whether Rac1 regulation requires kinase activity not fully resolved\"]\n    },\n    {\n      \"year\": 2012,\n      \"claim\": \"Knockout kinome profiling and the MYCN repression axis connected CDKL5 loss to AKT-mTOR signaling and to control of neuronal proliferation/differentiation.\",\n      \"evidence\": \"Cdkl5 KO mouse kinome profiling, behavior; neuroblastoma overexpression, ChIP, reporter assays\",\n      \"pmids\": [\"23236174\", \"22921766\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Direct CDKL5 substrates in the AKT-mTOR cascade not identified\", \"Mechanism linking kinase activity to cell-cycle arrest unknown\"]\n    },\n    {\n      \"year\": 2013,\n      \"claim\": \"Identifying palmitoylation-dependent PSD-95 binding as the synaptic targeting mechanism explained how pathogenic C-terminal truncations impair spine formation.\",\n      \"evidence\": \"Co-IP, palmitoylation manipulation, RNAi spine phenotype, pathogenic mutant analysis\",\n      \"pmids\": [\"23671101\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Whether PSD-95 is a CDKL5 substrate not established\", \"Kinase targets at the synapse not defined here\"]\n    },\n    {\n      \"year\": 2015,\n      \"claim\": \"Defining the RPXSX substrate consensus through amphiphysin 1 phosphorylation provided the rule for predicting and validating CDKL5 substrates.\",\n      \"evidence\": \"In vitro kinase assays with Amph1/Amph2 mutants and motif mutagenesis\",\n      \"pmids\": [\"25905439\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Physiological role of Amph1-Ser293 phosphorylation later questioned\", \"Cellular context of phosphorylation not addressed\"]\n    },\n    {\n      \"year\": 2016,\n      \"claim\": \"DYRK1A phosphorylation at Ser-308 and shootin1 interaction extended CDKL5 regulation to upstream control of localization and to axon specification.\",\n      \"evidence\": \"Co-IP, in vitro kinase assay, phosphomimetic mutants; yeast two-hybrid, RNAi epistasis in neurons\",\n      \"pmids\": [\"27840050\", \"26849555\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Whether shootin1 is a direct CDKL5 substrate not firmly established\", \"In vivo significance of Ser-308 phosphorylation untested\"]\n    },\n    {\n      \"year\": 2017,\n      \"claim\": \"Showing CDKL5 restrains postsynaptic GluN2B-SAP102 NMDA receptors and functions at the centrosome/midbody revealed both synaptic excitability control and a mitotic role.\",\n      \"evidence\": \"KO mouse PSD fractionation, immunoEM, patch clamp, pharmacological rescue; RNAi and H2B-S14D rescue in mitotic cells\",\n      \"pmids\": [\"28688852\", \"28740074\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Direct NMDA receptor substrate not identified\", \"Relationship between mitotic and neuronal functions unclear\"]\n    },\n    {\n      \"year\": 2018,\n      \"claim\": \"Unbiased chemical-genetic and phosphoproteomic substrate identification established MAP1S, EB2, ARHGEF2, CEP131, and DLG5 as physiological substrates linking CDKL5 to microtubule dynamics and cargo trafficking.\",\n      \"evidence\": \"Analog-sensitive kinase, SILAC phosphoproteomics, phospho-antibodies, KO mice, live EB3 imaging, rescue\",\n      \"pmids\": [\"30266824\", \"30266925\", \"29618004\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"How substrate phosphorylation maps onto disease phenotypes incompletely defined\", \"AMPAR GluA2 regulation mechanism partly correlative\"]\n    },\n    {\n      \"year\": 2019,\n      \"claim\": \"SMAD3 phosphorylation and GABAergic-specific loss-of-function linked CDKL5 to neuronal survival and to NMDA-receptor-dependent autistic-like behaviors amenable to pharmacological rescue.\",\n      \"evidence\": \"In vitro kinase assay, KO neuron survival, TGF-β1 rescue; GABAergic conditional and R59X knockin mice with NMDAR antagonist rescue\",\n      \"pmids\": [\"30793413\", \"31201320\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Direct SMAD3 phospho-site not detailed in narrative-relevant terms\", \"Cell-type-specific substrate basis of behavior unresolved\"]\n    },\n    {\n      \"year\": 2020,\n      \"claim\": \"Discovery of CDKL5 as a stress-responsive pro-death kinase phosphorylating SOX9 in renal epithelium revealed a function outside the nervous system.\",\n      \"evidence\": \"Kinome RNAi screen, RTEC conditional KO, SOX9 kinase assay, pharmacological inhibition, AKI mouse models\",\n      \"pmids\": [\"32317630\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Whether SOX9 regulation occurs in neurons unknown\", \"Tissue-specific determinants of CDKL5 pro-death versus pro-survival roles unclear\"]\n    },\n    {\n      \"year\": 2021,\n      \"claim\": \"Identifying transcription-coupled, PAR-dependent recruitment to DNA damage sites with Elongin A phosphorylation, plus demonstrating an adult requirement, redefined CDKL5 as both a genome-protective nuclear kinase and a persistently required regulator.\",\n      \"evidence\": \"Nuclear phosphoproteomics, PAR binding, DNA damage recruitment imaging, kinase-dead analysis; temporal KO/rescue mice with behavior and electrophysiology; cell-type KO seizure models\",\n      \"pmids\": [\"34605059\", \"34651584\", \"33400301\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"How nuclear DNA-damage role relates to synaptic functions unknown\", \"Glutamatergic versus GABAergic substrate differences not molecularly resolved\"]\n    },\n    {\n      \"year\": 2023,\n      \"claim\": \"Establishing Cav2.3 as a direct substrate and the kinase domain alone as sufficient for synaptic vesicle endocytosis tied CDKL5 to neuronal excitability as a partial channelopathy and to presynaptic membrane trafficking.\",\n      \"evidence\": \"SILAC phosphoproteomics, recombinant electrophysiology, phosphomutant knockin mice; SV reporter assays with kinase-dead and domain constructs\",\n      \"pmids\": [\"38081835\", \"36759195\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Endocytosis substrate distinct from amphiphysin 1 not identified\", \"Contribution of Cav2.3 to overall CDD phenotype quantitatively undefined\"]\n    },\n    {\n      \"year\": 2024,\n      \"claim\": \"Defining p62 phosphorylation in virophagy and CDKL2 compensation of EB2 phosphorylation expanded CDKL5 function to selective autophagy and revealed kinase redundancy in vivo.\",\n      \"evidence\": \"Co-IP, p62 mutant kinase assays, neurotropic virus KO mice; cell-type KO with phospho-antibody, in vitro kinase screen, dual Cdkl5/Cdkl2 KO mice\",\n      \"pmids\": [\"37917202\", \"38326557\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Extent of CDKL2 compensation across substrates unknown\", \"Whether virophagy defect contributes to CDD pathology untested\"]\n    },\n    {\n      \"year\": null,\n      \"claim\": \"How CDKL5's many substrates and subcellular roles are coordinately deployed across cell types and developmental stages to produce its disease phenotype remains unresolved.\",\n      \"evidence\": \"\",\n      \"pmids\": [],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"No structural model of CDKL5 substrate engagement or autoinhibition\", \"Hierarchy and relative phenotypic weight of substrates undefined\", \"Mechanisms governing spatial partitioning between nuclear and synaptic functions unknown\"]\n    }\n  ],\n  \"mechanism_profile\": {\n    \"molecular_activity\": [\n      {\"term_id\": \"GO:0140096\", \"supporting_discovery_ids\": [0, 16, 21, 22, 24, 26, 27, 30, 33]},\n      {\"term_id\": \"GO:0016740\", \"supporting_discovery_ids\": [0, 16, 21, 22, 30]},\n      {\"term_id\": \"GO:0140657\", \"supporting_discovery_ids\": [16, 21, 22]}\n    ],\n    \"localization\": [\n      {\"term_id\": \"GO:0005634\", \"supporting_discovery_ids\": [1, 3, 6, 27]},\n      {\"term_id\": \"GO:0005829\", \"supporting_discovery_ids\": [3, 6, 17]},\n      {\"term_id\": \"GO:0005886\", \"supporting_discovery_ids\": [13, 19]},\n      {\"term_id\": \"GO:0005815\", \"supporting_discovery_ids\": [20]},\n      {\"term_id\": \"GO:0005654\", \"supporting_discovery_ids\": [7]}\n    ],\n    \"pathway\": [\n      {\"term_id\": \"R-HSA-112316\", \"supporting_discovery_ids\": [9, 13, 19, 29, 30]},\n      {\"term_id\": \"R-HSA-162582\", \"supporting_discovery_ids\": [9, 11, 24]},\n      {\"term_id\": \"R-HSA-73894\", \"supporting_discovery_ids\": [27]},\n      {\"term_id\": \"R-HSA-9612973\", \"supporting_discovery_ids\": [33]},\n      {\"term_id\": \"R-HSA-5653656\", \"supporting_discovery_ids\": [31]},\n      {\"term_id\": \"R-HSA-1640170\", \"supporting_discovery_ids\": [20]}\n    ],\n    \"complexes\": [],\n    \"partners\": [\"MECP2\", \"RAC1\", \"DLG4\", \"DYRK1A\", \"SHTN1\", \"EB2\", \"SQSTM1\"],\n    \"other_free_text\": []\n  }\n}","audit_flag":{"gene":"CDKL5","tier":"GROUNDING","verdict":"Evidence-grounding concern","subtype":"fabrication","uniprot_band":"sparse","rules_fired":"R7","issue":"R7: fabricated (no corpus paper): 30266925"},"evaluation":{"pairwise":"win","faith_supported":8,"faith_total":8,"faith_pct":100.0}}